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RESUSCITATION PREFERENCES IN SURVIVORS OF PROLONGED 
MECHANICAL VENTILATION (PMV)/TRACHEOSTOMY  
 
 
Kathleen Guentner, RN, PhD 
 
 
University of Pittsburgh, 2004 
 
 
 
Background: Resuscitation preferences regarding prolonged mechanical ventilation (PMV) 
have rarely been explored. Objectives: To determine preferences of PMV survivors and 
influencing factors. Methods: Subjects were 29 (57% male) survivors of PMV (  7 days) and 
tracheostomy interviewed > 6 weeks after MV was initiated. Subjects were asked to: 1) indicate 
if they would choose MV again; 2) rate present health, pain/discomfort in ICU and from MV, 
perceived family financial burden and emotional/physical stress using a Likert scale (0=positive, 
4=negative); 3) identify change changes that might alter this preference; and 4) complete 
questionnaires assessing quality of life (QoL) (SF-36), functional status (Health Assessment 
Questionnaire), depressive symptoms (Center for Epidemiological Studies Depression Scale) and 
communication (Patient Communication Survey). Results: Most (76%) would undergo PMV 
again. Median MV days were greater for those who would undergo MV again (98.5 vs. 70, 
p=NS), as were median tracheostomy days (102 vs. 64, p=NS). Those who would not undergo 
MV again were more likely to have depressive symptoms (p=0.051) and Medicare coverage 
(p=0.023). No other variables differed between groups, including age, ICU length-of-stay, QoL, 
functional status, or communication status. Individuals who preferred MV stated their preference 
would change if their health and/or the family s emotional/physical stress were worse. Those 
who did not prefer MV would change if family s financial burden and emotional/physical stress 
were reduced. Conclusions: Most patients would undergo PMV again despite substantial time on 
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MV. Preferences were most likely to change based on present health and family s financial 
burden and stress.  
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1 THE PROBLEM 
 
1.1 INTRODUCTION 
Care in the intensive care unit (ICU) is associated with significant costs and critically ill 
patients who require prolonged mechanical ventilation (PMV) account for a substantial 
proportion of these costs (Heyland, Konopad, Noseworthy, Johnston, & Gafni, 1998).  Although 
most individuals who require mechanical ventilation (MV) during an acute illness are quickly 
weaned from ventilatory support, a minority, estimated at 3 to 6% of all patients admitted to the 
ICU, require prolonged weaning (Rudy, Daly, Douglas, Montenegro, Song, & Dyer, 1995; 
Douglas, Daly, Brennan, Gordon & Uthis, 2001).  The cost of caring for patients who are 
difficult to wean is related to the time and effort-intensive nature of the weaning process, 
extended stay in acute and long-term care facilities, and the morbidity associated with increased 
time on the ventilator (Clochesy, Burns, Shekleton, Hanneman, Knebel, & Ingersoll, 1997).     
In addition to the high costs associated with treatment, a prolonged ICU stay is associated 
with a high mortality. In studies conducted within the past 10 years, mortality rates for patients 
who require PMV were 43%, 67%, and 61% at 2, 6, and 12 months after hospital discharge, 
respectively (Quality of life after mechanical ventilation in the aged study investigators [QOL-
MV], 2002; Chelluri, Grenvik & Iverman, 1993; Seneff, Wagner, Thompson, Honeycutt & 
Silver, 2000).  Higher mortality was associated with increased severity of illness, increased age, 
and poorer physical functioning before hospitalization (QOL-MV, 2002).  Further, the need for 
PMV is an indication of increased severity of illness and prolonged recovery trajectory (Douglas, 
Daly, Gordon & Brennan, 2002).  
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Another outcome of prolonged critical illness is decline in physical functioning and 
subsequent need for an extended stay in long-term care facilities.  Although one study reported 
that the majority of patients were independent in several daily activities, such as bathing, 
dressing, feeding, and walking from room to room, at six months following ICU discharge 
(Niskanen, Ruokonen, Takala, Rissanen, & Kari, 1999), most studies report a decline in physical 
functioning (Chelluri et al, 1995; QOL-MV, 2002; Wissam, Kreimer & Criner, 2001).   In a 
prospective study that enrolled 817 patients who required MV for ³ 48 hours, Chelluri et al 
(2002) found that patients’ physical functioning was worse at 2 months following ICU discharge 
compared to before hospital admission.  Hoffman, et al (2002) reported that only 20% of patients 
were discharged to home 1-month following ICU discharge and 39% at 4-months after discharge 
in a prospective study that enrolled 80 patients who required MV for ³ 7 days.   
Most studies examining outcomes following PMV have focused on physical functioning, 
quality of life (QoL), morbidity, mortality and the care giving experience.  Patient preferences 
regarding PMV have rarely been explored (Mendelsohn, Belle, Fischhoff, Degenholtz & 
Chelluri, 2002).  Other studies that examined preferences were anticipatory in nature.  Patients 
were asked about future end-of-life decision-making, use of advanced directives, or treatment 
preferences for conditions likely to require MV such as end-stage chronic obstructive pulmonary 
disease (COPD), amyotrophic lateral sclerosis, and muscular dystrophy (Tilden, Tolle, Garland 
& Nelson, 1995; Hofmann, et al, 1997; and McKinley, Garrett, Evans & Danis, 1996).  It is 
unclear whether patients, who have already experienced an episode of acute illness, including 
PMV, would have the same preferences as they verbalized before the event (Mendelsohn, et al 
2002).  In order to fully examine preferences in this setting, it is important to elicit preferences 
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from the perspective of those individuals who survived PMV and, therefore, have first hand 
knowledge of its impact.   
In one of the few studies to investigate patient preferences after prolonged ICU 
admission, Teno and colleagues (2000) evaluated decision-making and outcomes for critically ill 
patients with an ICU length of stay of at least 14 days.  Although 55% of these patients died 
within 6 months, and those surviving had a significant functional impairment, only 34% of 
patients or surrogates had discussed preferences with their physicians by the second week of 
hospitalization.   In a second study of patient preferences, Mendelsohn et al. (2002) interviewed 
survivors of PMV (> 48 hours; median of 8 days) or their surrogates at one year after ICU 
discharge and found that most (86.5%) would again elect to have MV.  A strength of this study 
was the prospective long-term follow-up.  However, a substantial proportion of the original 
sample died (43% at 2 months) and 21% were lost to attrition (QOL-MV, 2002).  In addition, 
PMV was defined as > 48 hours, whereas the more common definition is > 7 days (Wissam et al, 
2001; Seneff et al, 2000; & Phelan, Cooper & Sangkachand, 2002).  No studies were identified 
that examined patient preferences in regard to again undergoing MV when the initial period of 
time on MV was > 7 days.   
There are a number of factors that might influence patient preferences regarding MV 
including its potential impact on ability to regain previous level of physical functioning, QoL, 
communication status, and depression.  Survivors of PMV have been shown to have decreased 
QoL compared with the general population (Chatila, Kreimer, & Criner, 2001). Nasraway et al, 
2000 described the outcomes of 97 survivors of prolonged critical illness, of whom 73.2% 
experienced PMV.  One year later, only 11.5% of all patients had returned home and reported a 
fair or better quality of life, and good physical functioning. 
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Communication status may greatly impact patients’ preferences regarding MV, but this 
aspect of functioning has received little examination.  Initially, MV is provided with an 
endotracheal tube, which eliminates the ability to speak.  Extended use of an endotracheal tube, 
especially for periods > 7 days, may result in hoarseness (41-71% of patients), vocal cord 
immobility (19%), and laryngeal stenosis (0-5%) resulting in impaired speech (Stauffer, 1999).  
To minimize risk and promote patient comfort, a tracheostomy is typically performed after 7-10 
days of MV if the patient is unable to wean from MV or has problems managing airway 
secretions (Hefner, 1993).  However, the need for a tracheostomy may also compromise patient 
ability to communicate, especially if a cuffed tube is required (Orringer, 1999).  Although 
several augmentative communication methods can be used to assist communication, e.g., paper 
and pencil, tracheostomy tubes with speaking valves, and computer keyboards, such devices are 
infrequently and inconsistently used in the ICU setting (Happ, 2001). 
Following chronic critical illness, limitations in physical functioning, QoL, and 
communication status, and depressive symptoms have often been observed.  While we know that 
13.7% of patients are depressed when admitted to the ICU (Rincon et al, 2001), recuperation 
from an extended hospital stay continues long after discharge and can result in a greater 
incidence of depression.  In the QOL-MV study (2002) described above 35% of 232 patients 
who required PMV (> 48 hours) had symptoms of depression 2 months following hospital 
discharge.  
Although, Mendelsohn et al (2002) found that patients, who survived 48hours of MV, 
continue to prefer MV, patients’ preference after experiencing PMV (> 7 days) and tracheostomy 
are not known.  Given the potential for compromise in physical functioning, QoL, 
communication ability, and depressive symptoms, it would seem likely that some patients would 
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prefer not to undergo MV if given the choice again.  Further study is indicated to better define 
patient preferences for this significant and growing sub-population of the chronically critically ill 
and factors that may influence these preferences.  This information would be beneficial to health 
care team members who discuss issues related to end of life decision making so as to better 
understand preference toward PMV from the patient perspective.  
 
1.2 PURPOSE OF THE STUDY 
The purpose of this preliminary study was: to elicit preferences regarding MV in patients 
who received PMV and tracheostomy and characteristics associated with these preferences and 
obtain pilot data for power analyses for a subsequent investigation.  This study provided 
information about preferences of patients that clinicians can use to inform discussions of 
treatment options and decision-making with patients and families. 
 
1.3 SPECIFIC AIMS 
The specific aims of this study were: 
1. to describe patient preferences regarding the use of MV in 2-month survivors of PMV and 
tracheostomy;  
2. to examine relationships between MV preference and selected potential influencing factors 
including demographics, clinical characteristics, quality of life, functional status, depressive 
symptomatology, and communication status; 
3. to obtain pilot data to facilitate estimating the sample size needed to insure adequate power 
for a subsequent study.   
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1.4 DEFINITION OF TERMS 
Prolonged mechanical ventilation (PMV): individuals treated with positive pressure 
ventilation via endotracheal intubation for > 7 days.   
Tracheostomy: the opening or stoma made in the trachea during a tracheotomy – the 
surgical incision into the trachea.  A tracheotomy tube is a short artificial airway inserted into the 
trachea during a tracheostomy operation. 
Cognitive functioning: absence of cognitive impairment, as measured by the Mini-mental 
State Exam (MMSE) (Folstein, Folstein & McHugh, 1975). 
Quality of Life: In this study, quality of life (QoL) or specifically, health related quality 
of life (HRQoL) was defined as the way patients perceive and react to their health and to 
nonmedical aspects such as their residence situation and employment (Wehler, Geise, 
Hadzionerovic, et al, 2003).  In this study, QoL was measured using the Short Form General 
Health Survey (SF-36v2) (Ware, Kosinski, 2002). 
Physical functioning: the ability to perform the functions of daily living, such as bathing, 
eating, dressing, meal preparation, etc.  In this study, physical functioning was measured using 
the Health Assessment Questionnaire (HAQ) (Fries, Spitz, Kraines & Holman, 1980).   
Communication status: communication is the act of transmitting ideas through speech, 
writing, or other methods; communication status encompasses communication success, 
satisfaction and ease of communication.  In this study, communication status was measured 
using the Patient Communication Survey (Happ, Roesch, & Kagan, unpublished data).   
Depressive symptoms: the symptoms of an emotional state characterized by decreased 
appetite, sleep difficulties or increased fatigue, feelings of hopelessness and helplessness or 
fluctuations in mood, and indecisiveness and lower self-esteem with self-criticism.  In this study, 
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depressive symptomalogy was measured with the Center for Epidemiological Studies Depression 
Scale (CES-D) (Radloff, 1977).  
Preference: the choice of something judged to be better.  Preference for mechanical 
ventilation was measured with the instrument described in Mendelsohn et al, 2002. 
 
1.5 SIGNIFICANCE TO NURSING 
Nurses are interested in identifying patient preferences toward life sustaining treatments 
to individualize their care.  This is especially true in settings such as the ICU where some of the 
treatments, such as MV, can be viewed as artificial life support.   Further, many patients admitted 
to the ICU have conditions associated with a high mortality, severe functional deficits, and an 
extended recovery.  With patient and family input, the interdisciplinary treatment team may 
choose a plan of care that emphasizes comfort and pain relief to accommodate the patient’s 
preferences.   
Patients are routinely asked upon admission to a hospital about their preferences as they 
relate to advanced directives.  “Advanced directives are instructions given by a patient while he 
or she has decisional capacity concerning medical treatment he or she would or would not like to 
receive in the event that decisional capacity is lost (Ahronheim, Moreno & Zuckerman, 2000, p. 
23).”  Sometimes those preferences or advance directives are written in the form of a living will 
or individuals may identify a durable power of attorney for health care.  In a living will, a person 
requests that, if they become disabled beyond reasonable expectation of recovery, the decisions 
about care made a priori be followed.  This is a powerful method to document preferences.  
However, individuals make advance directives based on sources other than experience.  The use 
of MV is often considered an extraordinary measure, and as such, is often included in a living 
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will, along with treatments such as blood transfusions, tube feedings, and antibiotics.  With very 
few exceptions, the individual writing a living will is likely to never have experienced MV, let 
alone PMV and tracheostomy. 
Most studies that have examined recovery following PMV report that patients require a 
substantial period of time to regain their prior physical functioning, or never regain this ability 
(QOL-MV, 2002).  In addition, the personal and economic cost of a critical illness and 
subsequent recuperation is significant and may have long-term implications for the family.  
Often this care is provided in a setting designed to provide a lower level of care, e.g., long-term 
acute care, acute rehabilitation, or skilled nursing facility.   This recovery period may be 
followed by home care and outpatient services to help the person return to optimal health and 
functioning.  Some patients spend the remainder of their life in a facility dependent for assistance 
with activities of daily living.  When individuals become dependent on others for care at home or 
in an institution, there is a high cost to the family in lost wages, stress and anxiety.   
It is important to learn about preferences following PMV and tracheostomy and examine 
how these preferences relate to perceptions of QoL, physical functioning, depressive symptoms 
and communication status.  The information obtained from participants in this study may be 
useful in assisting other patients and families to make decisions about life support when facing a 
similar scenario.  Additionally, ICU nurses often wonder about outcomes of patients they 
transfer to lower levels of care and how the patient feels about the outcome.  Findings of this 
research may lead to nursing interventions that help patients and families make decisions about 
MV and tracheostomy and offer emotional support during a difficult time. 
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1.6 INNOVATION 
This study was innovative in the following ways: 
No prior studies were identified that evaluated patient preferences following PMV (>7 
days) and tracheostomy. 
The study described outcomes following PMV and tracheostomy in a comprehensive 
manner that include measures of QoL, physical function, depressive symptoms and 
communication status. 
Study findings were designed to provide new insights into the preferences of a subset of 
patients who require extended support during their recovery from critical illness.  
  
1.7 CONCEPTUAL FRAMEWORK 
The conceptual framework for this study was based on an autonomy perspective in which 
medical treatment decisions are self-determined by patients and are directly related to the 
individual’s experience or understanding of and preference for the treatment (Ahronheim, 
Moreno, & Zuckerman, 2000).  “Autonomy is a concept anchored in humanistic and democratic 
ideals, with the recognition of a person's right to shape his life and destiny, influence decisions 
relating to his daily routine, and take an active part in his environment” (Barkay & Tabak, 2002) 
When able, individuals provide treatment decisions for MV by considering current health, pain 
and discomfort from MV, pain and discomfort experienced in the ICU, the burden family 
members experienced related to finance and emotional and physical stress (Mendelsohn et al, 
2002). 
Little is known about how individuals who experience PMV and tracheostomy perceive 
this experience, specifically whether they would undergo this treatment again or refuse this 
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therapy.  In this framework, patient preference for MV treatment was viewed as being influenced 
by several factors including physical functioning, QoL, communication status and depressive 
symptoms. In this conceptualization, it was hypothesized that patients who experience a greater 
reduction in QOL and physical functioning, have more difficulty communicating and more 
depressive symptoms would be less likely to chose MV if offered this opportunity again. 
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Figure 1 Conceptual Framework for Resuscitation Preferences 
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2 REVIEW OF LITERATURE 
 
 Today, people are living longer than at any other time in history.  In no small part, the 
increased life expectancy is due to medical advances that can prevent cure and treat illness and 
disease, and ultimately prolong life. Unfortunately, medicine cannot accurately predict the long-
term outcome of acute illness and the treatments provided (deVos, 2001).  Therefore, it is 
important for consumers of health care to consider potential illnesses and the possible 
consequences.   
 The need for advanced directives was highlighted following the highly visible Quinlan 
case.  Karen Ann Quinlan was the first case in the right-to-die debate.  In 1975, the 21-year-old 
Quinlan collapsed after taking alcohol and tranquilizers at a party. She suffered brain damage 
and lapsed into a persistent vegetative state.  Her family waged a much-publicized legal battle for 
the right to remove her life support machinery because the judge ruled that the physician’s 
decision would prevail when it differed from the family’s desire (Davis, Aroskar, Liaschenko & 
Drought, 1997).   
 A presidential commission was appointed in the early 80s to investigate ethical issues 
facing the country, the President’s Commission for the Study of Ethical Problems in Medicine 
and Biomedical and Behavioral Research.  This group issued a report, Deciding to Forego Life-
Sustaining Treatments, that stated that nothing in the law prohibits ethical decision-making or 
requires patients to receive painful procedures if they wish to avoid life-sustaining treatments 
(Davis et al, 1977).   This report set the stage for patient and surrogate decision-making 
regarding life sustaining treatments. 
In 1991 the Patient Self Determination Act (PSDA) was enacted into law.  The PDSA  
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“mandated that health care institutions and health maintenance organizations participating in 
Medicare and Medicaid programs provide patients with written information regarding their legal 
rights as outlined by state law; participate in medical decisions, including the right to accept or 
refuse treatment; and formalize treatment wishes by completing an advanced directive” 
(Maxfield et al, 2003, p38).   
In 1998 it was estimated that “…despite diligent efforts by the American Association of 
Retired Persons (AARP), local senior citizen groups, community educators, lawyers, and 
medical personnel to teach the public about their legal rights, only about 15% of patients have 
advance directives in the form of a living will or health care proxy” (Haynor, 1998, p.26).  
AARP has been very active in educating seniors about advanced directives.  Education, provided 
by AARP, appears on the American Medical Association web site and provides the rationale for 
having an advanced directive. 
  “… If you cannot make or communicate decisions because of a temporary or 
permanent illness or injury, a Health Care Advance Directive helps you keep control over 
health care decisions that are important to you. In your Health Care Advance Directive, 
you state your wishes about any aspect of your health care, including decisions about life-
sustaining treatment, and choose a person to make and communicate these decisions for 
you.   
Appointing an agent is particularly important. At the time a decision needs to be 
made, your agent can participate in discussions and weigh the pros and cons of treatment 
decisions based on your wishes. Your agent can decide for you wherever you cannot 
decide for yourself, even if your decision-making ability is only temporarily affected. 
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Unless you formally appoint someone to decide for you, many health care providers and 
institutions will make critical decisions for you that might not be based on your wishes. 
In some situations, a court may have to appoint a guardian unless you have an advance 
directive. 
An advance directive also can relieve family stress. By expressing your wishes in 
advance, you help family or friends who might otherwise struggle to decide on their own 
what you would want done. (http://www.ama-assn.org/public/booklets/livgwill.htm, July 
24, 2003).” 
This statement succinctly explains the need for advanced directives to give individuals 
control over their care by stating their preferences a priori.  The statement also explains the role 
of proxy decision-makers who can be authorized to make decisions that the individual would be 
likely to make, if able (substituted judgment).  The challenge occurs when individuals fail to 
make advanced directive or discuss their preferences with a surrogate decision-maker.  In such 
situations, family members may provide consent (make care decisions) regarding life-sustaining 
treatments.  However, these decisions do not have guidance from the person receiving the care.   
This literature review was completed by searching MEDLINE and CINAHL from 1966 
to present to identify studies investigating end of life decision making; patient preferences 
following an ICU stay; QoL, physical function and depression following ICU, prolonged ICU, 
MV, prolonged MV; tracheostomy; and communication.  The following terms were used: 
decision-making, patient decision-making, QoL, physical functioning, depression, ICU stay, 
MV, prolonged MV, tracheostomy, tracheotomy, and communication.  Citations were limited to 
human studies and the English language.  In addition, the reference lists of relevant articles were 
reviewed to identify additional papers.   
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2.1 FACTORS INFLUENCING END-OF-LIFE DECISION-MAKING 
When patients’ decisions about end of life situations, life-sustaining treatments, and 
intensive care have been examined, the most common approach has been to ask the individual to 
project what they might want in various situations.  The following selected studies identify the 
varied factors that can influence preferences, including race, desire for physician input into 
decision-making, family input, and stability of decisions over time. 
 McKinley, Garrett, Evans, and Danis (1996) examined the differences in African-
American and white individuals’ preferences regarding end of life decision-making.  The 
participants were 206 ambulatory cancer patients who were over 40 years old and under 
treatment by a medical oncologist.  The study consisted of a 35-minute interview that included 
90 closed-ended questions and several open-ended questions.  The items asked about life 
sustaining treatments in general, and specifically about cardiopulmonary resuscitation, feeding 
tubes, ICU monitoring, and MV support.  African-American patients were significantly more 
likely to prefer life-sustaining treatments (Odds ratio 2.8; 95% CI 1.4-5.3) and less likely to want 
to complete a living will (OR 0.36; 95% CI  0.17-0.75) than whites after controlling for 
socioeconomic variables.  Nevertheless, the majority agreed that a living will would provide 
control over their terminal care.   
 Hofmann and colleagues (1977) examined preferences about communicating with 
physicians regarding end-of-life decisions, specifically cardiopulmonary resuscitation and PMV.  
However, they did not provide a definition of “prolonged”.  Entry criteria required that patients 
have one of 9 diagnostic categories: acute respiratory failure, COPD, congestive heart failure, 
cirrhosis, nontraumatic coma, metastatic colon disease, advanced non-small cell lung cancer, 
multiorgan system failure with sepsis or multiorgan system failure with a malignant condition.  
Patients were ineligible if they were comatose, intubated, could not communicate, were 
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cognitively impaired, or were discharged before the interview window.  Of those approached, 
1832 agreed to be interviewed and 330 were not interviewed.  Most (90%) who were not 
interviewed refused participation.  Compared with those interviewed, those who refused to 
participate were more likely to be white (94% vs. 84%, p< 0.001) and have a worse prognosis for 
survival at two months (71% vs. 76%, p < 0.001).  The groups were similar with regard to age, 
gender and religious preference.   
 Of the 1223 patients who had not discussed their preference for cardiopulmonary 
resuscitation with their physician, 42% wanted to have that conversation and 70% wanted their 
physician to revive them.  The 366 patients who had discussed preference for cardiopulmonary 
resuscitation with their physician were more likely to have advanced directives that stated no 
resuscitation.  Most (88%) of those patients who responded to questions about PMV had not 
discussed preferences with their physician.  Patients who had discussed preferences for MV with 
their physician were more likely to have advanced directives and to state that they did not want 
PMV (p < 0.006).  
 In addition, family decision-making has been examined when the patient was unable to 
make end-of-life decisions in regard to perceptions of physician and nurse behaviors during the 
process (Tilden, Tolle, Garland, & Nelson, 1995).  The authors interviewed 32 family members 
of patients whose death resulted when care was withdrawn.  Inclusion criteria required the 
patient be ≥ 21 years old, unable to make decisions at the time of death, hospitalized for ≥ 3 days 
before death, have no advanced directive, and have a family member who participated in the 
decision to withdraw life support.  Behaviors of healthcare providers that families found 
supportive included encouraging advanced planning, timely communication, clarification of 
family roles, facilitating family consensus, and accommodating grief.  Participants described 
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behaviors that lead to feelings of burden were related to attitude, communication, and timing of 
withdrawal, such as staffing rotations, withdrawal of care being discussed at the bedside and 
physicians who appear to view the patient’s death as treatment failure.   
 Additional studies have considered whether patient decisions would be stable (not 
change) after an advance directive was made, e.g., would the patient have the same preferences 
months or years later.  Everhart & Pearlman (1990) interviewed ICU patients to determine 
preferences for life-sustaining treatments, such as resuscitation, resuscitation with MV, and 
artificial hydration and nutrition, considering their current health and the possible scenarios of 
stroke and dementia.  Thirty patients were interviewed immediately prior to or within 24 hours of 
ICU discharge and 20 of these individuals were interviewed again approximately 1 month 
following ICU discharge (20-40 days).  Most patients preferred resuscitation in their current state 
of health (87%), but preference for resuscitation declined if the participant imagined stroke or 
dementia.  Less than half (43%) of these participants favored resuscitation with MV if their 
current state of health involved stroke (27%) or dementia (24%).  These preferences were found 
to be stable after 1 month (kappa=0.35 – 0.70).   
 In summary, factors that have been shown to influence patient decision making about end 
of life situations, include race, communication with physician, helpful behaviors of health care 
providers and the stability of the decision over time.   It has been shown that African–American 
patients appear to prefer life-sustaining treatments, but would be less likely to have a living will.  
When patients prefer to decline treatment, they tend to inform their physician.  Families are 
supported when they make end of life decisions by actions such as advanced care planning, 
timely communication, and facilitating family agreement.  When patients make decisions about 
advance directives such as resuscitation and MV, the decisions appear to be stable to 1 month 
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based on a study of 20 patients.  Clinicians can utilize this information when caring for patients 
and families.   
 
2.2 PREFERENCES FOLLOWING ICU ADMISSION  
 In an early study, Danis, Patrick, Southerland, & Green (1988) interviewed 160 patients 
and family members who were in a medical or respiratory ICU for at least 24 hours regarding 
preferences for intensive care and the importance of the patient’s life circumstances in 
determining those preferences.  The patients were at least 55 years old and lived nearby the 
hospital (to facilitate interview).  The patients were divided into 4 outcome groups: Group I 
(n=69), alive and competent, therefore patients were interviewed; Group II (n=8), alive but not 
competent to be interviewed; Group III (n=37), survived hospitalization to live at home for at 
least 30 days, but died before participation; and Group IV (n=46), patients who died during 
hospitalization or within 30 days of hospital discharge.  Families were therefore interviewed for 
Groups II, III and IV regarding decisions they would make for the hospitalized person.  Median 
ICU length of stay was 3-5 days and mean (+SD) APACHE II scores were: Group I = 13 + 7, 
Group II = 12 + 4, Group III = 16 + 6 (p<0.05), and Group IV = 20 + 8 which indicates low 
acuity.   
Most patients (74%, n=51) stated they would be “completely willing” to undergo ICU for 
very brief periods of life prolongation.  Only 4% (n=3) stated they would be “unwilling” to 
choose ICU for any period of life prolongation.  Family preferences were similar.  Within 
Groups II, III and IV combined (n=60), 67% of family members said they would choose ICU 
care regardless of the life prolongation outcome.  Families of patients who died were 
significantly less likely to choose ICU (p=0.02).  Patients (n=11) and families (n=17) would not 
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choose ICU if there was no hope of recovery, if the patient would be kept alive by machines 
(n=7, n=10, respectively) and if the patient were vegetative or neurologically impaired (n=7, 
n=10, respectively).      
Elpern, Patterson, Gloskey, & Boone (1992) also reported findings from a study of 
patient preferences following a relatively brief ICU stay.  The sample was comprised of adult 
patients discharged from the medical/coronary ICU following a stay of ≥ 48 hours, all of whom 
were alert and oriented.  Patients were evaluated within 48 hours of discharge to determine 
eligibility and interviewed according to their availability and tolerance.  Most participants (96%) 
stated they preferred life support to restore their usual state of health.  If they were to remain 
mentally competent but be functionally dependent, this percentage decreased to 67%.  If they 
were terminally ill, the percentage decreased further to 36% and to 30% if they were in a 
permanent vegetative state.  As in the previous study, the average ICU length of stay was 
relatively short (4.5 days) and the mean APACHE II score (13.3) indicated low acuity.  ICU stay 
and APACHE II scores were significantly higher (4.8 days and 17.9, respectively; p < 0.003) for 
patients who did not participate in the interviews.   
 More recently, researchers have examined decision-making and outcomes following 
substantially longer (> 14 day) ICU stays (Teno et al, 2000).  The sample was recruited from 5 
ICUs.  Patients (n=1457) were at an advanced stage of the following conditions: non-traumatic 
coma, acute respiratory failure, multiple organ system failure with sepsis or malignancy, chronic 
obstructive pulmonary disease, congestive heart failure, cirrhosis, metastatic colon cancer, or 
inoperable non-small cell lung cancer.  The patient or a family decision-maker was interviewed 
during the second week of hospitalization when the majority (91%) were still in the ICU.  
Slightly less than half of patients/families (45%) preferred a life extending approach, while 36% 
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expressed a preference for comfort even if it shortened life.  The authors did not distinguish 
between the preferences provided by patients or family members.  However, it is likely that 
because most of the patients were very ill family members would have been the primary 
decision-makers.  Whether their decision was the same as that of the patient is not known. 
 In one of the few studies that focused on MV, Mendelsohn et al (2002) examined 
patients’ preference for MV following a period of > 48 hours of ventilator support.  A total of 
115 patients/family members were interviewed with the Patient Preference Tool one year 
following ICU admission.  The patients were recruited from medical, neurological, trauma and 
general surgery ICUs.  When the patients/family decision-maker was interviewed, 86.6% 
indicated they would choose MV again, with younger (< 65 years old) (p = 0.0006) (90% vs. 
68%) and healthier (92.5% vs. 77.4%, p = 0.01) having higher odds of choosing MV compared 
to older and sicker patients.  In addition, the authors examined the relationship between 
preference and QoL.  Those patients who were more likely to choose MV had significantly better 
physical function as measured by the SF-36 physical component (p = 0.004), the activities of 
daily living (ADL) (p = 0.02) and instrumental activities of daily living (IADL) (p = 0.004).   
In summary, most patients who experienced an ICU stay would be willing to experience 
a repeat ICU stay for even brief prolongation of life, but there were only 69 patients in this 
sample, who had experienced a median ICU stay of 3 days.  Preference for life support increases 
if there would be a return to usual health, with a reduction in the number of people who prefer 
life support under the condition of functional or cognitive decline.  Patients experiencing a 
longer ICU stay tend to have a reduced desire for continued life support or repeat treatment.  
Consequently, preference for ICU care and life support appears to be related to resultant QoL 
and physical functioning.    
  32
2.3 QUALITY OF LIFE, PHYSICAL FUNCTION, & DEPRESSION 
   Chelluri et al (1993) examined QoL, physical function, and symptoms of depression in 97 
elderly (>65 years) individuals following an ICU admission of approximately 7 days.  Patients 
were excluded from the study if they were admitted to the ICU following uncomplicated elective 
surgery, transplantation, or had a poor prognosis secondary to cancer.  Survivors were evaluated 
at 1, 6 and 12 months post hospital discharge.  In this sample, mean APACHE score was 18 + 
0.9, mean ICU LOS was 5 + 1.1, and duration of MV was 5 + 0.9 days for patients 65-74 years 
of age (n=43).  Among patients > 75 years old (n=54), mean APACHE score was 20 + 0.8, mean 
ICU LOS was 7 + 1.1 and mean duration of MV was 6 + 0.9 for patients.  QoL, measured by the 
perceived quality of life index (PQOL), tended to increase over the time post discharge for 
patients 65-74 years of age (n=12) and those > 75 years old (n=12), and there was no significant 
difference.  Physical functioning data, measured by the ADL index, was available for 32 
participants.  Most of the patients were independent pre and post hospitalization and there were 
no significant differences.  Depressive symptoms, measured using the CES-D, decreased over 
time when comparisons were made at the three follow-up time periods (10, 8.5, 6; p = 0.009).  
Although the sample was small, the PQOL and CES-D results are similar to previous reports of 
elderly cohorts living in the community, who did not experience an ICU admission. 
 Konopad, Noseworthy, Johnston, Shustack and Grace (1995) studied all adult (> 17 years 
old) patients admitted to a medical-surgical ICU with the exception of patients who died within 
24 hours of admission.  Although 504 patients were enrolled, only 293 completed the data 
collection at 12 months.  Attrition was due to refusal (n=6), lost to follow-up (n=79), and death 
(n=126).   If the patient was unable to complete the questionnaires, a proxy was asked.  Table 1 
shows the composition of those completing both sets of questionnaires.   
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Table 1  Number of patients and proxies completing questionnaires 
Baseline & 12-month questionnaires N=293 
Patient completed both 226 
Patient baseline, proxy at 12 months 11 
Proxy baseline, patient 12 months 40 
Proxy completed both 16 
 
The perceived health for the total group was significantly higher at 12 months (p< 0.05); 
when patients completed the questionnaires for both time periods, perceived health was 
significantly higher (p < 0.05).  Physical function, based on level of activity and ADL, decreased 
significantly (p<0.001) from baseline compared to one year later.  
Eddleston, White & Guthrie (2000) evaluated the outcome of ICU patients alive at 3 
months post ICU discharge.  The outcomes of interest were survival, ICU related psychological 
morbidity, QoL, and employment status.  Patients were contacted 8 weeks following ICU 
discharge to schedule a 12-week clinic interview, which consisted of questionnaire completion 
and interview.  Follow-up at 6 and 12 months was done via telephone.  During admission to the 
ICU, there were 370 eligible patients for the study; at 3 months, 227 were alive and 143 agreed 
to participate.  Of interest, all deaths after 3 months occurred in those that declined participation.  
Approximately 80% were satisfied with the speed of their recovery at 3 months, although 
complaints of fatigue continued for 12 months (38.2% of women, 32% of men).  Of note, 
everyone who had been employed prior to ICU admission had returned back to work by 12 
months.  Seven patients (2 men, and 5 women) had increased depression scores on the Hospital 
Anxiety and Depression Scale (HAD), but only 1 man had clinical depression that required 
treatment. 
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Rivera-Fernandez, Sanchez-Cruz, Abizanda-Campos & Vazquez-Mata (2001) conducted 
a prospective, observational study in Spain to examine QoL prior to an ICU admission.   A 
patient or family member was interviewed using a researcher developed QoL instrument upon 
admission to the ICU.  The admission QoL score was lower for patients who personally 
responded, then for those for whom a family member responded (3.62 + 4.24 vs. 3.94 + 4.66, 
respectively; p< 0.005).  Although most patients had a good QoL prior to ICU admission, the < 
10% who did not had a higher mortality (p< 0.001).  In addition, lower QoL scores were 
associated with higher APACHE III score (r= 0.217, p < 0.001) and older age (r=0.289, p< 
0.001), supporting that older, sicker patients had a poorer QoL prior to admission.  
Chelluri et al (2004) examined QoL, physical function and depressive symptoms 
following > 48 hours of MV in 817 patients admitted to either a medical, neurologic, trauma, or 
surgical ICU.  The survivors (n=359) were interviewed 12 months following the ICU stay.  If 
patients were cognitively impaired or unable to participate because of medical condition, proxies 
were interviewed for all but the depression instrument (patient interview, n=155; proxy 
interview, n=76).  Patients or proxies were asked to self-rate health status of the patient 
compared to one year ago.  The majority (62%; n=106) rated their health as much better or 
somewhat better than one year ago.  Mean scores for physical function using the ADL (ranges 0-
6, with 6 indicating dependence) were 0.59 ± 1.28 for patients and 2.89 ± 2.52 by proxy.  For 
IADL (ranges 0-8, with 8 indicating dependence), mean scores were 3.38 ± 2.86 for patients and 
5.01 ± 2.96 for proxy responses.  Scores on the SF-36 physical function component (ranges 0-
100, with lower score indicating dependence) were 52.3 ± 33.09 for patients and 31.58 ± 38.17 
by proxy.  The depressive symptomalogy score as evaluated by the CES-D (scores > 16 indicate 
the presence of depressive symptoms) was 12.16 ± 11.02 for patients.  Using a proportional odds 
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logistic model analysis, the factors (after adjusting for patient type, gender, and ICU acuity) 
associated with functional decline were age and baseline IADL scores.   
In summary, the potential that patients who experience an ICU stay of less than seven 
days will return to pre-hospital status appears to be influenced by their age, pre-hospital physical 
functioning, and acuity.  There are differences when surrogates are asked to assess QoL; patients 
self-rated QoL higher than proxy ratings.  When adult patients, including the elderly, gave 
responses, ratings of perceived health were significantly higher than for proxies, but physical 
functioning was decreased.  Patients who survived to 3 months following an ICU stay, 
complaints of fatigue continued for 12 months, but those employed prior to the ICU stay had all 
returned to work.  In a study done in Spain, poor pre-ICU QoL was associated with higher acuity 
and older age.   
 
2.4 QUALITY OF LIFE, PHYSICAL FUNCTION & DEPRESSION FOLLOWING 
PMV 
 In a sample of patients recruited from a broad variety of ICUs, researchers (QOL-MV, 
2002) enrolled patients who had been on MV > 48 hours, (median 8.6 days).   Patients or proxies 
were interviewed during hospital stay and two months after ICU admission.  The interviews were 
done either in person by telephone if the patient lived > 50 miles from the hospital.  The 2-month 
mortality was 43%.  The median (25th, 75th percentile) ADL score was 0 (0, 4) (n=261); IADL 
was 4 (0, 6) (n=213); SF-36 physical functioning was 25 (5, 70) (n=223).  A higher score on all 
indicates greater dependence.  Median ADL and IADL scores for patient results were 1 and 4, 
whereas proxy results were 5 and 7. Median SF-36 physical for patients was 30, but was 0 for 
proxies.  The CES-D median was 14 and 13 (6 to 20) indicating that the patients were at risk for 
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depression.  These results demonstrate decreased functioning from pre-hospital condition and a 
disagreement between scores provided by patients and proxies.   
Researchers in Finland reported on the QoL and physical functioning of patients 
requiring a prolonged ICU stay of > 4 days (mean 13.6 ± 11.8 days; n=718) and compared them 
to the general population (Niskanen et al, 1999).  The Nottingham Health Profile, designed to 
measure QoL and a modified ADL index to measure physical function were mailed to the 
patients 6 months after ICU admission.  Although some did not answer all questions, more than 
85% reported functioning independently and the greater the independence, the greater the QOL.  
It appeared that physical functioning and QoL were related to increased length of time in the 
ICU. 
In a study designed to compare outcomes of short (<24 hours) (mean 2.4 + 1.3 days) and 
long term (>96 hours) (mean 16.3 + 17.8 days) MV, Douglas, Daly, Gordon, & Brennan (2002) 
interviewed patients who had been admitted to an ICU by telephone within 2 weeks of hospital 
discharge and at 6 and 12 months to assess functional and psychosocial status.  None of the 
clinical or demographic variables were significantly related to QoL as measured by the Sickness 
Impact Profile (SIP) at 12 months after adjusting for discharge QOL.  Patients who required 
short term MV tended to have better QoL than long-term MV patients at all three time periods, 
but the difference was not statistically significant.  Short-term patients did have a significantly 
better physical functioning at all three time periods (p=0.048).  In addition, the short-term 
patients were more mobile (p=0.04) and better able to care for themselves (p=0.022). 
Carson, Bach, Brzozowski & Leff (1999) reported outcomes of 133 patients who were 
transferred to a long-term acute care facility (LTAC) after spending > 14 days on mechanical 
ventilation.  Mean age was 71 +12 years and the patients had 3.2 + 1.6 comorbidities.  Median 
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ICU stay prior to LTAC admission was 25 days (range 9-123 days) and all had a tracheostomy.  
The researchers contacted 1-year survivors or family by telephone to gather survival and 
physical functioning data.  At 1 year, 66 (50%) patients had died in the LTAC, 51 (38%) were 
weaned from MV, 67 (50%) were discharged from the LTAC, and 30 (23%) survived 1 year.  At 
LTAC admission, 19 (63%) of the survivors had been independent.  At 1-year, 11 (8% of total 
sample & 42% of 1-year survivors) participants were oriented, ambulatory, and independent.   
Nasraway et al (2000) examined the 1-year outcomes in 97 patients transferred to an 
extended care facility (ECF) after a > 7 day ICU stay.  Mean ICU stay was 39 days (range 7-276 
days).  The majority (96.9%, n=94) were on MV in the ICU, and 73.2% (n=71) were on MV at 
discharge from the ICU.  At one year, 49 (50.5%) patients had died, 16 (16.5%) remained in an 
ECF, 3 (3.1%) remained in an acute care hospital 3 (3.1%), 4 (4.4%) where in a nursing home, 
and 24 (24.7%) were discharged to home.  Thirty patients were interviewed and half rated their 
QOL as good or excellent and 9 (30%) as fair.  Mean scores on the Barthel Activities of Daily 
Living Index were 11.5 + 7.6, which indicates functional dependence. 
In a study examining patients who had undergone an extended period of MV resulting in 
admission to a hospital-based ventilator rehabilitation unit, Chatila, Kreimer, & Criner (2001) 
reported on outcomes of patients who required MV for 45 + 36 days.  Patients or caregivers 
(n=46) were contacted by phone 1-2 years (23 + 18 months) after their discharge from the unit.  
Those patients that agreed to participate (n=25) were contacted again three years (n=14) after the 
first phone call.  The majority of patients had a physical score of 12 + 12 on the Sickness Impact 
Profile (SIP), with the worse functioning in sleep and rest, ambulation, and physical dimension.  
During the 1-2 year follow-up evaluation, there were no significant differences in scores when 
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compared with the first evaluation.  In this study, older patients (r=-0.40; p=0.045) had better 
QoL after recovery.   
 In addition, studies have examined the QoL of patients undergoing specific types of 
procedures that resulted in ICU admission, most commonly cardiac surgery.  In a study by 
Engoren, Buderer & Zacharias (2000) patients who had cardiac surgery and required PMV (> 7 
days) were contacted by phone, one to seven years post ICU discharge.  During the study time 
frame, a minority (3%; n=123) of the 4,073 patients required PMV.  Of these, 19 (15%) died in 
the hospital and 51 (41%) died after discharge.  Of the 53 survivors, 40 participated in phone 
interviews.  Some participants had limitations with ADLs (16%), more had limitations with 
moderate activity (60%), and most with vigorous activity (94%).  Almost half (41%) had no 
limitations at home or work and most (59%) described their general health as good to excellent.   
Findings of this study support improved recovery in patients who undergo surgical procedures 
where the goal is resolution of the underlying condition.  In patients who require ICU admission 
due to exacerbation of a chronic underlying health problem, e.g., COPD, outcomes may be less 
positive.  
 In summary, it has been shown that PMV is associated with high mortality, decreased 
QoL, functional limitations, and risk of depression.  Decline in QoL and physical functioning 
appears to be related to length of time in the ICU and on MV.  It seems that if this population 
survives for a year, about half of them will rate their QoL as good and be functioning 
independently, especially if a surgical procedure resulted in the ICU stay.    
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2.5 TRACHEOSTOMY 
As the patient progresses to a chronic need for MV, physicians begin to consider the need 
for tracheostomy.  It has generally been accepted that patients who require short term MV are 
well served with an endotracheal tube whereas those on long-term ventilation are better suited 
with a tracheotomy (Heffner, Miller, & Sahn, 1986 and Lewis, 1992). Two primary factors 
evaluated when considering the decision to perform a tracheostomy include anticipated time on 
MV and the discharge plan.  The advantages of tracheotomy include decreased risk of airway 
complications when PMV is required and the ability to facilitate weaning from MV and nursing 
care, specifically airway suctioning and mouth care.  In addition, having a tracheostomy 
promotes increased patient mobility because the tube is more secure which allows easier bed-to-
chair transfer, allows transfer to a lower level of care, improves patient comfort, facilitates 
speech, allows oral nutrition, and psychological benefit (Lewis, 1992).   
While there is agreement on the need for tracheostomy, there is no consensus on the ideal 
time for tracheostomy.  In 1989, Bishop stated that the timing of tracheostomy should be driven 
by nursing issues – ease of nursing care, patient comfort, ability to communicate, and appearance 
to the family.  He further stated that tracheotomy should be performed when the patient is 
medically stable, rather than because of the hypothetical benefit of sparing the larynx.  Rodriguez 
and colleagues (1990) concluded that, in a homogenous group of critically ill patients, early 
tracheostomy was associated with a significant decrease in duration of MV, as well as shorter 
ICU and hospital stays, compared with endotracheal intubation.  There were no deaths attributed 
to tracheostomy and overall morbidity of the procedure was 4%.  They concluded that early 
tracheostomy has an overall risk equivalent to endotracheal intubation.  Furthermore, they 
asserted that early tracheostomy shortens days on MV, in ICU, and in hospital and should be 
considered for patients in the ICU at risk for more than 7 days of intubation. 
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Heffner (1991) critically reviewed studies that have investigated timing of tracheostomy.  
He began with the premise that no available study definitively establishes an absolute ideal time 
for tracheostomy.  His recommendations were that if extubation appears probable within 7 to 10 
days from the onset of respiratory failure, tracheostomy should be avoided.  Conversely, if it 
appears airway support will be required for > 21 days, an early tracheostomy should be 
performed to enhance patient care and comfort at the first opportunity after patient stabilization.  
When the anticipated duration of intubation appears unclear, he recommended daily re-
evaluation.  The author fails to provide guidance for patients on MV for 11 – 20 days.   
Lesnik, Rappaport, Fulginiti, and Witzke (1992) retrospectively examined the medical 
records of 101 patients who had sustained a blunt, multiple organ injury and underwent 
tracheostomy.  Group I (n=32) had the procedure performed within the first four days of injury 
(early tracheostomy) and Group II (n=69) more than 4 days after surgery (late tracheostomy).  
There was no significant difference between the two groups in terms of age, Injury Severity 
Score, Glasgow Coma Score, and associated injuries.  Mean MV time for Group I was 6.0 + 3.4 
days and for Group II was 20.6 + 12.2 days (p< 0.001).  In addition, Group I had 6 (19%) 
nosocomial pneumonias versus 41 (59%) in Group II (p< 0.001).     
Brook et al (2000) conducted a prospective cohort study of 90 consecutive patients in the 
medical ICU comparing patients who had an early tracheostomy with those having a late 
tracheostomy.  Early tracheostomy (N=53) was defined as a procedure performed by day 10 of 
MV and late tracheostomy (N=37) after day 10.   Tracheostomy was performed at 5.9 + 7.2 days 
in the early group and at 16.7 + 2.9 days in the late group (p<0.001). The early trach group had 
lower mean APACHE II scores on the first 24 hours of the ICU admission, a lower prevalence of 
ARDS, and fewer females compared to the late tracheostomy group.  In addition, PaO2/FiO2 
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ratio was significantly greater in the early tracheostomy group than in the late tracheostomy 
group.  Mean duration of MV was significantly shorter for the early tracheostomy group (28.3 + 
28.2 days) compared to the late tracheostomy group (34.4 + 17.8 days) (p<0.005).  In addition, 
the authors found that the ICU length of stay for the early trach group was 15.6 + 9.3 days versus 
29.3 +15.4 days (p< 0.001) for the late trach group.  While these findings suggest that early 
tracheostomy may benefit patients by facilitating less time on the ventilator and reducing time in 
the ICU and hospital, there were substantial between group differences that suggested lower 
acuity of illness in the early tracheostomy group, e.g., lower APACHE scores, lower incidence of 
ARDS, higher PaO2/FiO2 ratio. 
 
2.6 COMMUNICATION STATUS 
There are frequent accounts of patients having difficulty communicating while in the ICU 
because of the critical nature of the illness, endotracheal intubation for MV, and medications that 
may be prescribed for analgesia and sedation (Happ, 2001; Connolly & Shekleton, 1991; 
Menzel, 1998).  The inability to speak has been identified as the cause of feelings of anxiety, 
fear, and panic (Menzel, 1998; Bergbom-Engberg & Haljamae; 1989; Rotondi et al, 2002).   
Pennock, Crawshaw, Maher, Price and Kaplan (1994) interviewed patients who were transferred 
out of the Surgical ICU (SICU) within 48 hours of coronary artery bypass surgery to determine 
which events occurring in the SICU were considered stressful.  Patients (n=127) were asked to 
rate 23 potential stressors for degree of stress using a 4-item Likert scale (1- no stress to 4- 
extremely stressful), developed by the researchers.  Participants were able to add to the list as 
well.   A majority of patients (79% of 100 patients) rated endotracheal tubes and the inability to 
talk as extremely stressful or stressful.  Improved communication techniques may help eliminate 
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this stressful experience, not only for acutely ill patients but also patient with PMV and 
tracheostomy. 
The distress due to the inability to communicate is not unique to the United States, 
researcher in Sweden (Bergbom-Engberg & Haljamae, 1989) interviewed patients that 
experienced MV and found similar results.  Patients were telephoned 2 months – 4 years after 
MV.  If the patient could remember the experience of MV (n=158), they were interviewed for 1-
2 hours about their ICU experience.  Patients stated that fear and anxiety (47%) and the inability 
to talk (46%) was most distressful.   The duration of MV was 6.4 + 11.2 days (range 3 hours – 83 
days).  Patients on MV for > 7 days described their ICU stay as more threatening than patients on 
MV for 4-7 days.  The authors did not mention if any of the patients had a tracheostomy.   
Communication is compromised in the ICU because of critical illness, intubation, 
tracheostomy, neuromuscular disease, and paralytic medications.  When the patient is unable to 
speak, communication in the ICU typically consists of non-vocal behaviors, for example 
mouthing words, hand gestures, and eye blinks (Happ, 2001).  To prevent the fear, anxiety and 
stress associated with voiceless in the ICU, patients are assisted to write messages on paper or a 
‘magic slate’, use alphabet boards, and computers (Lawless, 1975; Cronin & Carrizosa, 1984).   
There are additional options to facilitate speech including an electrolarynx, a self-
activated pneumatic voicing system, a speaking valve, and a speaking tracheostomy tube (Leder, 
1990; Connolly et al, 1991; Happ, 2001).  Evidence suggests that these techniques are 
infrequently and inconsistently applied.  Although respiratory therapists occasionally initiate use 
of speaking valves, involvement of a speech therapist is dependent on a consultation with this 
discipline.  “The significance of improved communication in ICU includes the ability to improve 
social interaction, the amelioration of suffering, patient participation in treatment decision-
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making, and completion of relationships at the end of life (Happ, 2001, p.258).”  Patients 
experienced an improved sense of well being when they could talk with a tracheostomy 
speaking-valve, and appeared happier and interacted better with family and nursing staff 
(Manzano, Lubillo, Henriquez, Martin, Perez & Wilson, 1993; Leder, 1990: Bell, 1996: Byrick, 
1993).  
Menzel (1998) examined the relationship between the intensity of intubated patients’ 
feelings of anger and fear/worry at being unable to speak and severity of illness, communication 
status, the number of communication methods used, time on MV, MV history, and reason for 
MV.  The intensity of emotional response was measured with the Emotion Scale, specifically the 
subscales for angry and worried/fearful, adapted by the researcher.  The subscales were rated on 
a 5-point Likert-type scale, with responses ranging from “not at all” to “a great deal.”   
Communication status was measured with a researcher-developed tool, consisting of 6 items 
rated on a 5 point Likert type scale.  Mean scores on the emotion subscales indicated that the 
participants had moderate feelings of anger and worry/fear due to inability to speak.  The patients 
used an average of 3.6 communication methods.  Increased severity of illness (p< 0.05) and 
greater difficulty with communication (p < 0.001) were significantly associated with more 
intense feelings of anger at being unable to speak.  Fewer MV days (p < 0.05) and greater 
difficulty with communication (p < 0.001) were significantly related with feelings of worry/fear 
at being unable to speak.  Interestingly, patients’ emotional responses and ease of 
communication scores changed 20% from intubated responses to post intubation responses, 
indicating instability of responses.    
Researchers have also investigated types of communication aids that patients use when 
MV is required after hospital discharge.  Bach (1993) reported outcomes from 89 patients 
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diagnosed with amyotrophic lateral sclerosis (ALS) who were supported by MV for 4.4 + 3.9 
years.  Most (n=76) had a tracheostomy and the remainder was supported with non-invasive MV.   
Several types of communication methods were used including verbal (n=32), computer aided 
(n=21), non-verbal aids (n=32) and complete loss of communicative ability (n=4).  Patients 
satisfied with the mode of communication established were more likely to remain at home and 
reported substantially improved QoL. 
In summary, patients experience stress, anxiety, and worry because of the inability to 
communicate during acute critical illness resulting in MV.  Long term it has been shown that 
patients who are satisfied with their ability to communicate have improved QoL, but no research 
has been done to examine the relationship between communication status and preference toward 
MV.   
 
2.7 SUMMARY 
Little research has focused on the preferences toward MV following PMV (> 7 days) and 
tracheostomy, is the goal of this research.  Two outcomes, QoL and physical functioning, have 
been the focus of most studies, examining long-term outcomes in patients experiencing PMV.  
Few studies have examined symptoms of depression and communication status.  The goal of this 
study was to more broadly examine outcomes in patients who experienced PMV and 
tracheostomy including QoL, physical functioning, as well as symptoms of depression and 
communication status.  Most prior studies used proxy decision makers to describe QoL and 
physical functioning when patients were unable to participate and findings indicate the responses 
often differ between patients and proxies.  This research will collect preference data from 
patients to describe QoL, physical functioning, depressive symptomalogy and communication 
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status.  Research has shown that long-term mortality for this population is high; therefore, data 
will be collected at 2 months to facilitate timely collection of this information and recruitment of 
a large sample.  In addition, several sites, including hospital step down units, long-term acute 
facilities, and long-term care facilities will be used to access this population. 
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3 PRELIMINARY STUDY 
 
A pilot study was done to describe decision-making about tracheostomy in medical ICU 
patients.  The purpose was to describe the decision-making process undertaken by family 
members when asked to provide consent for tracheostomy in patients admitted to a medical 
intensive care unit (MICU).  The research questions (RQ) answered by this pilot study were: 
1. What factors influenced families in their decision to provide consent for 
tracheostomy tube placement? 
2. What physician and nurse behaviors facilitated family decision-making  
regarding tracheostomy tube placement? 
3. What behaviors hindered family decision-making regarding tracheostomy tube 
placement? 
 
3.1 BACKGROUND 
Patients who develop acute respiratory failure are typically managed with positive 
pressure mechanical ventilation and endotracheal intubation, a procedure that involves insertion 
of an airway into the nose or mouth (Whited, 1984).  Endotracheal intubation can be quickly 
performed and quickly reversed in the event of improvement of the patient’s condition (Austin, 
1971).  Therefore, it is the procedure of choice in emergent situations.  Prolonged endotracheal 
intubation predisposes the patient to a number of risks.  Laryngeal damage may result because 
the curvature of the endotracheal tube exerts pressure against the posterior laryngeal structures 
(Bishop, 1989).  In addition, complications may result from excessive pressure of the 
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endotracheal tube cuff against the tracheal mucosa, which may produce mucosal ulceration and 
tracheomalacia (Lewis, 1992).  Unplanned extubation, a major complication of endotracheal 
intubation, occurs in 3% to 16% of ventilator dependent patients and has the potential to worsen 
outcome by increasing mortality and prolonging ICU and hospital stay (Epstein, 2000). There are 
also important clinical considerations that result from the discomfort patients’ experience from 
prolonged endotracheal intubation (Heffner, 1999).   
For this reason, a tracheotomy is typically performed when prolonged intubation is 
required (Plummer & Gracey, 1989).  There are several advantages to using a tracheostomy for 
airway management.  A tracheostomy decreases airway resistance, which reduces the work of 
breathing, a factor that may promote weaning from mechanical ventilation (Diehl et al, 1999).  
Additional advantages include increased patient mobility (bed-to-chair transfers) by providing a 
more secure tube.  There may be increased patient comfort because a tube holder is not required 
and decreased patient anxiety because it is easier to communicate with the health care team and 
family, with a consequent decrease in sedation needs.  Tracheostomy may facilitate nursing care, 
specifically airway suctioning and mouth care (Heffner, 1999).  Together, these factors may 
promote a more rapid recovery, resulting in shorter ICU and hospital length of stay (LOS).   
However, families may view a request to provide consent for tracheostomy differently.  
The request may be viewed as an indication that the patient will not recover or that recovery may 
be extended for weeks or months.  Families may view the request as the first step in preparing 
for transfer to another health care institution and wish to delay this outcome.  
Family decision-making regarding the care of critically ill patients has primarily been 
studied in regard to withdrawing life-sustaining treatment.  When making decisions about life-
sustaining treatment, there are indications that families go through a series of steps that include 
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framing the question, reasoning about the decision, identifying a family spokesperson, and 
interacting with the healthcare team to obtain additional information (Tilden, Tolle, Garland, & 
Nelson, 1995).  From interviews with families asked to make such decisions, Tilden and 
colleagues identified physician and nursing behaviors that were viewed as helpful to families 
including encouraging advanced planning, timely communication, clarification of families’ roles, 
facilitation consensus among family members, and allowing expression of the family’s grief.  In 
several studies of decision-making about treatment for patients with cancer (Davison, Degner, & 
Morgan, 1995, Wallberg, Michelson, Nystedt, Bolund, Degner, & Wilking, 2000, and Pyke-
Grimm, Degner, Small & Mueller, 1999), researchers reported that some patients preferred 
collaboration with their physician so that they were completely informed, but the majority 
preferred a passive role, allowing the physician to make decisions.  Younger, educated patients 
tended to take a more active role in decision-making.  Given long intervals spent in the ICU 
waiting room, it is likely that families also may also ask other families for their opinion. 
Psychological aspects related to tracheostomy have been examined in several studies 
enrolling pediatric patients who received a tracheostomy.  Baumgardner & Burtea (1998) 
assessed QoL in children who underwent tracheostomy in regard to family dynamics.  Positive 
QoL aspects included growth as individual, intrinsic rewards for the child, and appreciation of 
others with a disability.  Negative impacts on the family’s QoL were mental and physical 
anguish, inhibitions of normal family functioning, and isolation.  Cohen et al (1998) evaluated 
the QoL for children who had a tracheostomy for medically refractory obstructive sleep apnea 
versus surgery and reported that parents in the tracheostomy group ranked 95% of the items on 
their questionnaire as worse than parents in the surgery group.  Bach & Campagnolo (1992) 
evaluated the psychosocial adjustment of 380 ventilator-dependent post-poliomyelitis patients 
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who used a tracheostomy versus noninvasive positive pressure ventilation (NIPPV) and found 
that 14.7% in the tracheostomy group expressed dissatisfaction with their lives in general, 
compared with 8.5% for the NIPPV group.  Also, post polio individuals using NIPPV had higher 
(p<0.02) life satisfaction score than individuals with a tracheostomy.   
 Only one study was identified that assessed the perception of health care providers.  
Astrachan, et al., (1988) surveyed 60 critical care nurses to determine their perceptions of patient 
comfort and ease of care for patients with endotracheal intubation and tracheostomy.  A large 
majority (77%) preferred tracheostomy for patients who required airway support.  Almost all 
respondents (90%) felt that tracheostomy patients were more comfortable and, therefore, 
required less sedation and restraints.  The majority (97%) also felt that patients with 
tracheostomies could communicate more effectively, and that airway care was simplified.  In 
addition, 92% of nurses stated that they would prefer a tracheostomy for themselves or a loved 
one if more than 10 days of ventilatory support were required.  A limitation of this study was that 
it focused on perceptions and did not assess whether conversion to tracheostomy changed patient 
management, e.g., mobility, sedation needs.  Also, the study did not assess family perceptions. 
When a tracheostomy is advised, the family is often asked to give consent for the 
procedure because the patient is unable to provide informed consent.  A study of family decision 
making to withdraw life support in critically ill adults (Swigart, Lidz, Butterworth, and Arnold, 
1995) described it as a deliberate process that involved gathering information from several 
sources, integrating it emotionally, and obtaining consensus with the other family members.  Few 
studies have addressed how the family and patient (if able to provide consent) reason about the 
decision to provide consent for tracheostomy tube placement or attempted to identify physician 
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and nurse behaviors that facilitate family decision-making regarding this aspect of management 
or behaviors that hinder families and increase burden. 
 
3.2 SIGNIFICANCE 
Although most individuals on mechanical ventilation during an acute illness are readily 
weaned from ventilatory support once medically stable, a small percentage of patients require 
prolonged weaning (Rudy, Daly, Douglas, Montenegro, Song, and Dyer, 1995).  Health care 
providers agree that prolonged ventilator weaning causes stress, anxiety, and financial hardships 
for the family members of the ventilator dependent individual as they wait nearby for 
recuperation.  The process that families use to make proxy health care decisions during this time 
has not been thoroughly investigated.  Understanding the process that families utilize to make a 
treatment decision, such as consent for tracheostomy, will be helpful in shaping professional 
behaviors that are supportive of that decision making process.  Similarly, behaviors and 
communication styles that exclude family involvement or causes further burden can be identified 
and avoided.  
 
3.3 RESEARCH DESIGN AND METHODS 
Interviews were conducted with family members of patients who had given informed 
consent for tracheostomy tube placement in the MICU.  A semi-structured interview guide was 
used.  Family members were interviewed within 2 weeks of the procedure, as a result the 
experience would be fresh in their minds and they had an opportunity to recognize the benefits of 
their decision.   The participants determined the duration of the interviews.  The average has 
been about 30 minutes, and the longest has lasted an hour and twenty-five minutes.  The 
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interviews were audiotaped to preserve originality of the data.  The recordings were transcribed 
verbatim excluding personal identifiers. The interviewer made observational notes regarding the 
subject’s tone of voice and non-verbal behavior during the interview.  To ensure accuracy, the 
investigator read the transcripts while listening to the tapes.  In addition, observations noted of 
the subject’s body language (e.g., gestures, facial expressions) were inserted into the transcript. 
Once the audiotapes were transcribed, the tapes were destroyed.  The investigator also collected 
basic information about the patient on the Pilot Study Demographic Tool.  
3.3.1 Instruments 
 
The semi-structured interview guide was used to direct the face-to-face interviews with 
subjects. Demographic characteristics and information about the patient was collected on the 
Pilot Study Demographic Tool.  The information collected included the patient and family 
member’s age, gender, and race; the subject’s relationship to the patient, their years of education, 
and the primary decision-maker in the family prior to this illness from the family member’s 
perspective.  Patient data included gender, date of birth, age, race, diagnosis, reason for 
mechanical ventilation, Apache III score on admission and at the time of interview, any 
significant complications, e.g., sepsis, renal failure that occurred during this admission, number 
of days intubated prior to the tracheostomy, ICU and hospital length of stay on the interview 
date, and type of health care coverage.    
 
3.4 DATA COLLECTION AND STATISTICAL CONSIDERATIONS 
  Family interviews were audio taped, transcribed and analyzed to extract meaning from 
the data.  Analysis was concurrent with data collection.  The constant comparative method was 
used to analyze the transcribed interviews. This process involved review of transcripts with the 
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goal of identifying main categories of data through micro-level coding and grouping codes into 
categories and coding these categories. Interrelated categories were collapsed to formulate 
concepts significant to the decision-making process about tracheostomy tube placement.  
Concepts that recurred frequently and appeared meaningful were used to identify themes that 
described the decision-making process, behaviors that facilitated family decision-making and 
behaviors that hindered families’ decision making. Demographic data was analyzed with 
descriptive statistics and is used only to describe the sample. 
 
3.5 SAMPLE GENERAL CHARACTERISTICS 
The subjects for this pilot study were family members of 4 patients admitted to the MICU 
who require tracheostomy. The patient sample was selected purposively to include variability 
based on gender, age, and ethnicity characteristics.  The racial, gender and ethnic characteristics 
of the proposed subject population reflects the demographics of Pittsburgh and the surrounding 
area and/or the patient population of the University of Pittsburgh Medical Center.  There was no 
attempt to recruit subjects in respective proportion to these demographics.  No exclusion criteria 
shall be based on race, ethnicity, gender, or HIV status.  
 
3.6 INCLUSION/EXCLUSION CRITERIA  
The family member was 1) at least 18 years old; 2) able to understand and speak English; 
3) willing to be interviewed as part of the study; and 4) had given informed consent for elective 
tracheotomy tube placement for a family member in the MICU with a diagnosis of acute 
respiratory failure and no prior history of ventilator dependence or tracheostomy.  
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3.7 RECRUITMENT PROCEDURES 
Prior to initiation of the pilot study, the principal investigator met with the MICU 
treatment team to explain the study.  The medical director of the MICU informed the principal 
investigator daily of patients admitted who met the inclusion criteria.  Medical and nursing 
personnel informed the family about the study and the opportunity to voluntarily participate.  
They explained that care would not be affected by a decision to participate.  If a family member 
was willing to consider study entry, they were asked if their name and phone number could be 
given to the researcher, then the personnel notified the principal researcher.  Once potential 
participants authorized release of their name and phone number, the principal investigator 
contacted them and explained the study.   
The principal investigator met with the family member(s) in the location chosen by the 
family member, such as the patient room, quiet room or conference room.  The study was 
explained, it’s purpose, the subjects’ and investigator’s roles, the procedure for audio taping and 
interviewing. The principal investigator explained the potential risks and benefits of 
participation, privacy, confidentiality, and the right to decline enrollment or withdraw from the 
study without repercussions.  An opportunity for the family member to ask questions and 
consider participation was provided.  Once the investigator and family member agreed that the 
conditions of informed consent were met, the investigator and family member acknowledged 
agreement by signing the consent form. The interviews occurred at a time convenient for the 
family member.   The goal was to recruit family members who had been asked to provide 
informed consent for a tracheostomy procedure because the patient was unable to give consent.   
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3.8 DATA ANALYSIS 
Family interviews were audio taped, transcribed and analyzed to extract meaning from 
the data.  Data collection and analysis in the grounded theory method was a cyclic and reiterative 
process.  Analysis was done concurrent with data collection.  The constant comparative method 
was used to analyze the transcribed interviews (Strauss, 1987).  This process involved review of 
transcripts with the goal of identifying main categories of data through micro-level coding and 
grouping codes into categories and coding these categories.  Open coding was performed line-
by-line assigning axial codes to reflect the substance of the data.  Interrelated categories were 
collapsed to formulate concepts significant to the decision-making process about tracheostomy 
tube placement.  These axial codes were then assigned to build up a dense texture of 
relationships around the axis of the category (Strauss, 1987, p. 64).  Concepts that recurred 
frequently and appeared meaningful were used to identify themes that describe the decision-
making process, behaviors that facilitate family decision-making and behaviors that hinder 
families’ decision making and classified as core categories (Strauss, p. 36).   The relationship 
between core categories was proposed as a tentative conceptual framework for proxy decision 
making for tracheostomy.  Demographic data was analyzed with descriptive statistics and used 
only to describe the sample. 
 
3.9 RESULTS 
3.9.1 Proxy Decision Maker Characteristics 
 
Characteristics of the sample are displayed in Table II. They reflect diverse characteristics 
of proxy decision makers with regard to family relationship and sex.   
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Table 2 Demographics 
Family 
Member Age Gender Race Relationship 
Occupation 
of 
 decision 
maker 
Other family 
members 
present during 
interview 
1 33 F C Wife Secretary None 
2 64 F C Wife Retired RN Daughter 
3 77 M C Son Retired State 
Trooper 
None 
4 74 F C Wife Housewife 
3 daughters 
 
 
3.9.2 Codes 
 
There were 483 free nodes and 35 axial codes.  The Axial codes are included in Table III.  
Some of the axial codes were specific to one participant, but most were shared by all of them.   
  
Table 3 Axial Codes 
Presentation Consent If asked sooner 
Call for expert help Risks This experience 
Failure by expert Trach scheduled Acceptance 
Diagnosis Recovery Persuasion to seek treatment 
Key happening Restraints Hospital course 
Pre-impression of tracheostomy Sedation Planning 
Why trach Return of self Trach explained 
Trach first mentioned Communication Eased the trach idea 
Initial reaction Reaching equilibrium Patient understanding 
Nurse Worries Ventilator 
Persuasion for trach Post trach – physical Trust 
Learning about trach  Benefits 
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3.9.3 Core Categories  
 
Five core categories emerged from the analysis of the transcribed interviews.  These include 
groundwork, physician explanation, nurse support, risks and benefits, and self-work.   
3.9.3.1 Groundwork 
 
This category emerged as all of the proxies discussed their experience with giving 
permission.  The participants told about receiving a warning or hint or clue that tracheostomy 
was going to be discussed.  This gave them opportunity to begin self-work to learn more about 
tracheostomy.  The axial codes that merged to form groundwork include learning about 
tracheostomy, trach first mentioned, pre-impression of tracheostomy.  Proxies stated in the 
interviews statements that reflect this category: 
“…we discussed with her (Lisa, a cousin, RN) earlier that this was going to be a possibility – that 
she told us that it would be a possibility down the road – and it came true.  We were 
prepared…”(#3) 
“…I’ve dealt with them… I guess I made it easy for myself.” (#2) 
“one of the nurses was the first one who told me.  And she said, “Just so you know – if they can’t 
get him – you know, he’s not ready to go off the ventilator, they’re going to have to do the 
tracheostomy.” (#1) 
“And we learned and learned and educated ourselves and spoke to everybody we possibly 
could.” (#4) 
3.9.3.2 Physician Explanation 
 
All of the informants discussed at length the way the physician explained the family 
members condition and the rational for tracheostomy.  Several points were stressed: he sat down; 
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he explained in terms that they could understand, and he answered all of their questions.  The 
axial codes that were merged to form this concept include consent, explanation of tracheostomy, 
persuasion, and planning.  Statements that demonstrate this category include: 
“So, between the nurses and then Doctors D and K explained that to me…” (#1) 
“At the time Dr. D sat down and explained to me exactly what it was and made sure that I 
understood …” (#2) 
“It was easier with him just sitting down and explaining …” (#2) 
“He brought us into a room, talked to us about what my mother had; what he was doing, what he 
and his staff thought about what needed to be done; and told us all the… he explained it really 
well.” (#3) 
“Well the way he sat down and explained to us – we felt very confident that was the way to go.” 
(#3) 
“Dr. K. couldn’t have been more wonderful, more caring… and he explained it all to us.” (#4) 
3.9.3.3 Nurse support 
 
This category explained as all of the participants discussed the helpful communication 
with the nurses.  Some of the statements from the interviews that formed this category include: 
“The first nurse, her name was C… she even said that if somebody in her family – like her 
husband or father and they said ‘we need to do this’ she’d say ‘do it.” (#1) 
“With Jim’s situation, she said it’s definitely temporary.  She said it’s only to get him off the 
ventilator.” (#1) 
“And it was the nurse that explained it to her, not one of the doctors.” (#2) 
“… I made the nurse promise me that she would explain it to him when he woke up…”  (#2) 
  58
3.9.3.4 Risks and benefits 
 
This category emerged as all of the family members discussed the risks and benefits of 
tracheostomy.  The axial codes that were merged were consent, persuasion, learning about 
trachs, benefits, restraints, sedation, worries, recovery, eased the trach, and patient 
understanding.  Quotes from the interviews that highlight this concept includes: 
“…because it’s a good thing and it was better for him – and then when they said the risks of 
keeping the breathing tube in were to do permanent damage to your vocal cords, infection and 
things like that…” (#1) 
“…since they did the trach, they could take the sedation down.” (#1) 
“… it had to be done.” (#2 & 3) 
“… as long as it was a temporary procedure that was fine.” (#1 & 2 & 3) 
“It leaves a small scar.” (#3) 
“We thought it would help.” (#3) 
“… she sure would be better without that tube down her – then she’d breathe easier with this 
trach on her.” (#3) 
“Dr. K did it… he got three inches from my father’s face and told him everything.” (#4) 
“it would save his life” (#4) 
3.9.3.5 Self-work 
 
This category emerged as all of the participants discussed strategies that they used to learn 
more about tracheostomy.  The axial codes that were merged include paramedic boyfriend, 
minister, family members, past experience, and the Internet.  Direct quotes that represent this 
include: 
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“I knew it was a hole in the throat, and I’ve seen people with them.” (#1) 
“I talked to my parents about it and his father.” (#1) 
“…I mean I went home and looked up some stuff on the Internet…” (#1) 
“And I had spoken with the minister and he …” (#2) 
“I’ve seen enough done; been a part of enough that…” (#2) 
“I’ve actually dealt with clients that have a medical condition as well.” (#2) 
“I’ve been around.” (#2) 
“So we’ve discussed it with her (Cousin, RN).” (#3) 
“I’ve been taught to do a trach.” (#3) 
“My cousin’s wife is a respiratory therapist.” (#4) 
“… so we learned about all this stuff.” (#4) 
3.9.4 Discussion  
 
The proxies discussed a trajectory of acceptance and agreement with tracheostomy.  This 
trajectory consists of groundwork being laid with the suggestion that tracheostomy was a 
possibility.  When the physician sat down with the family, explained the treatment plan and 
rationale for tracheostomy, and answered the families’ questions, the family was in a position to 
agree with tracheostomy and give permission.  Nursing support, through an informal process 
substantiated the information given and provided emotional support.  The proxies all conducted 
some type of self-work, that consisted of talking to known health care professionals, talking to 
other family and friends, and investigating sources of knowledge such as the Internet.  It was 
beneficial when the information from all of these sources explained the risks and benefits of 
intubation and tracheostomy.  In each situation, observing any improvement in the family 
member after the tracheostomy reinforced the decision as a good one.   
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The concept of decision making as a process that includes emotional and value-laden 
factors has been described in the disciplines of nursing, psychology, and economics Swigart et 
al, 1998).  A rational-scientific model of decision making, similar to the "decision tree" that is 
often used for treatment protocols, is more familiar to health care providers (Swigart et al, 1998).  
This model of decision making that requires understanding of concepts and evaluation of the 
facts and possible outcomes is consistent with the process that the interviewed family members 
performed.       
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Third, no decision-makers were interviewed who did not agree to consent for 
tracheostomy.  Such individuals potentially could provide information on which heath care 
professional’s behaviors hindered proxy decision-making about tracheostomy. 
Fourth, only two physicians explained the patient’s condition and the procedure to the 
family members and only four family members were interviewed.  It would be interesting to 
examine the experience of proxy decision-makers that talked to other physicians in a larger 
sample.  Finally, only one ICU and one hospital were used, which limited generalizability of the 
data gathered.  
The results of this study can be used to guide the explanation and support provided to family 
members who are asked to make proxy health care decisions, such as permission for 
tracheostomy.  Regardless of the timing of tracheostomy placement and the decision making 
regarding placement, for patients receiving MV, tracheostomy is a visible sign of the transition to 
prolonged mechanical ventilation or “chronic critical illness.” Although these family members 
expressed satisfaction with the tracheostomy decision, little is known about the patient’s 
perspective about prolonged MV and the resultant recuperation.   
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4 METHODS 
 
4.1 SETTING AND SAMPLE 
This study was conducted at the University of Pittsburgh Medical Center (UPMC) Health 
System and six of its long-term care referral sites.  UPMC, a tertiary care facility, includes 9 high 
acuity ICUs that specialize in the care of medical (n=2), surgical (n=1), cardiac, cardiothoracic 
(n=3), neurosurgical, trauma (n=1), and transplant (n=2) patients.  When a ventilator-dependent 
patient stabilized, they may be transferred to a long-term care referral site. When a patient, who 
met entry criteria, was discharged from the hospital and provided consent to participate, they 
were contacted at least 6 weeks following the entry point (surviving 7 days on MV and 
tracheostomy). 
These facilities primarily served residents of Allegheny County which was comprised of 
Caucasians (83.8%), African Americans (12.4%), and Asians (1.7%) with nearly one-fifth 
(17.8%) of the population > 65 years old (2000 U.S. Census data, retrieved March 15, 2003, 
from http://quickfacts.census.gov/qfd/states/42/42003.html).  Greater Pittsburgh and Mountain 
View were located in Westmoreland County, which is adjacent to Allegheny County.  
Westmoreland County was comprised of Caucasians (96.6%), African Americans (2%), and 
Asians (0.5%) with a similar proportion of persons > 65 years of age (18.3%) (2000 U.S Census 
data retrieved September 27, 2003, from http://quickfacts.census.gov/qfd/states/42/42129.html).   
Study participants who met the following entry criteria were recruited:  1) able to speak 
English (needed for instrument completion); 2) >18 years of age; 3) on MV for at least 7 days; 4) 
received a tracheostomy during this episode on MV; alive 2 months post 7 days on MV; and 5) 
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cognitively intact as determined by the Mini-mental state examination (MMSE) (Folstein, 
Folstein & McHugh, 1975).     
 
4.2 STUDY DESIGN 
This exploratory study used a descriptive, cross-sectional design.  Descriptive statistics 
were computed to characterize and summarize the data and bivariate parametric and 
nonparametric correlational analyses (based on the distribution) were conducted to examine the 
relationships between MV preference and other study variables.  Each subject answered 5 
questionnaires to assess: 1) preferences toward MV for actual and hypothetical situations (QOL-
MV, 2002); 2) quality of life (Medical Outcomes Study [MOS] Short Form [SF]-36v2) (Ware, 
Kosinski & Gandek, 2002); 3) physical functioning (Health Assessment Questionnaire [HAQ] 
(Fries, Spitz & Young, 1980); 4) depressive symptoms (Center for Epidemiological Studies 
Depression Scale [CES-D] (Radloff, 1977); and 5) communication status (Patient 
Communication Survey [PCS] (Happ, Roesch, & Kagan, 2001-2003) The instruments were 
completed in the order listed during an interview session scheduled a minimum of 6 weeks 
(range 6 to 362.6 weeks) after the subject had been on MV for ≥ 7 days and received a 
tracheostomy.  One investigator obtained all study data.  The interview took place in the patients’ 
room and lasted approximately 1.5 hours.  All tools were administered verbally.  A laminated 
card was presented to the patient to select answers.  No proxy responses were used. 
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4.3 STUDY VARIABLES 
 
4.4 DESCRIPTIVE DATA 
4.4.1 Sociodemographic Characteristics 
 
Demographic data were collected using the Demographic Information Questionnaire 
designed for this study (Appendix A.1).  Variables of interest included: age, gender, ethnicity, 
education level, employment status prior to hospitalization, occupation, marital status, and 
insurance type.   
4.4.2 Clinical Characteristics 
 
Clinical data were obtained from the medical records using the Clinical Information Sheet 
designed for this study (Appendix A.2).  Variables of interest included: primary diagnosis, 
comorbidities (Charlson Comorbidity Score [Charlson, Pompei, Ales, MacKenzie, 1987]), at the 
time of data collection, ICU and hospital length of stay, indication for MV, dates of intubation, 
tracheostomy, weaning from MV and decannulation.  
4.4.3 Cognitive functioning 
 
The instrument used to assess cognitive functioning is the Mini-mental state examination 
(Folstein, Folstein, & McHugh, 1975).  This instrument is an 11-question general-purpose 
cognitive screening examination (Foreman, 1987) that exams the concepts of orientation, 
registration, attention and calculation, recall, and language.   This instrument, which takes about 
5 to 10 minutes to administer, quantifies the severity of cognitive impairment in persons with 
dementia or dementia-like conditions.  A standardized score of < 24 indicates cognitive 
impairment.  Patients with this score will be excluded from this study. 
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4.4.4 Dependent Variables 
 
4.4.4.1 Preference regarding MV 
 
The instrument used for assessing patient was designed for use in the Quality of Life After 
Mechanical Ventilation in the Aged Study (QOL-MV, 2002; Appendix A.3) to elicit preferences 
toward MV from critically ill patients who had recently received MV in an ICU.  This instrument 
consisted of 18 questions for the purpose of eliciting preferences toward MV from critically ill 
patients who had recently received MV in an ICU and took about 15 minutes to administer.  
Initially patients were asked whether they would have chosen MV, given their ICU experience.  
Then the patients were asked to rate five domains related to their ICU and post-ICU experience: 
present health, pain/discomfort from MV, pain/discomfort in the ICU, family financial burden 
resulting from hospitalization, and family emotional and physical stress (caregiver burden) 
resulting from hospitalization.  Each domain was measured on a 5-point Likert scale, ranging 
from 0 (positive side; i.e. excellent health, no pain/discomfort) to 4 (negative side; i.e. poor 
health, extreme pain/discomfort).  To reduce order effects, patients were given the opportunity to 
change their responses after answering all five questions.  If a response was changed, the new 
answer was recorded.  Patients were given an opportunity to identify situations, which would 
alter their preference for MV.  Then the levels of the five domains were manipulated individually 
until the patient changed his/her mind.  This was the indifference point; i.e. the point at which the 
patient had no preference between the two alternatives.   
This instrument can be administered in person or by telephone, but it was administered in 
person for this study.  The principal investigator was trained and evaluated on her ability to 
satisfactorily administer and record the participants’ responses for a series of practice interviews 
by the primary author of this instrument (Mendelsohn, 2002). 
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4.4.4.2 QOL 
 
QoL was measured with the Short Form General Health Survey (SF-36v2) (Ware, 
Kosinski & Gandek, 2002).  The SF36 was developed as a generic measure of physical 
functioning and well being (p.2: 3).   It was comprised of eight subscales: physical functioning, 
role functioning, bodily pain, general health, vitality, social functioning, mental health, and 
reported health transition. Scores on four subscores (physical functioning, role functioning, 
bodily pain, and general health) were combined to yield a physical component score and scores 
on the remaining four subscales (vitality, social functioning, mental health, and reported health 
transition) combined to yield a mental component score.  The total scores ranged from 0-100, 
where higher scores indicate greater QOL and general health. The reliability coefficients equal or 
exceed 0.80 (p. 7:4).  Internal consistency and item discriminate validity equals or exceeds 0.40 
(Ware, Kosinski & Dewey, 2000).  The SF-36 has been used successfully with individuals with 
both acute and chronic illnesses, including individuals experiencing MV (Eddleston et al, 2000).   
In ongoing research involving patients on MV, the time to complete this instrument ranged from 
15 to 20 minutes. 
4.4.4.3 Physical Functioning  
 
Physical Functioning was measured using the Health Assessment Questionnaire (Fries, 
Spitz & Young, 1980). The HAQ was first developed to evaluate physical functioning for 
patients with rheumatoid arthritis.  The tool quantifies 8 general constructs (dressing, grooming, 
arising, eating, walking, hygiene, reach, grip, and outside activity with 18 items that are scored 
from 0 – 3 (without any difficulty, with some difficulty, with much difficulty, unable to do), an 
item about use of aids or devices, such as a cane or wheelchair or help from another person.  The 
highest score on any question within the subdomain was the score for that subdomain.  Adding 
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the scores and dividing by the total number of components answered calculated the index.   This 
tool can be completed through self-administration, telephone or interview.  Internal consistency 
estimates ranged from 0.71(Milligan, Hom, Ballou, Persse, Svilar & Coulton, 1993) to 0.94 
(Pincus, Summey, Soraci, Wallston, & Hummon, 1983). Two-week test-retest reliability estimates 
ranged from 0.87 to 0.98 (Fries, Spitz & Young, 1982).  In 32 patients with COPD, researchers 
obtained 2-week test-retest reliabilities, which ranged from 0.972 to 0.975 (unpublished data). 
Validity had been assessed by examining relationships with the Functional Status Index (r=0.75) 
and the Sickness Impact Profile (r=0.78) (Liang, Larson & Cullen, 1985). In ongoing research 
involving patients on MV, the time to complete this instrument ranged from 3 to 8 minutes. 
4.4.4.4 Depressive symptomalogy 
 
Depressive symptomalogy was measured using the Center for Epidemiological Studies 
Depression Scale (CES-D) (Radloff, 1977).  This tool was a 20-item Likert scale, which included 
items of depressed mood, feelings of guilt and worthlessness, helplessness and hopelessness, loss 
of appetite and sleep disturbances.  Scores ranged from 0-60, with established scores of > 16 
suggesting risk of clinical depression.  Coefficient alpha ranged from 0.84-0.90.  Correlations 
with nurses, and other scales ranged from 0.44-0.75.  The time to complete this instrument 
ranged from 10 to 15 minutes. 
4.4.4.5 Communication status 
 
Communication status was evaluated using the Patient Communication Survey (Appendix 
A.7) (Happ, M, Roesch, T, Kagan, 2001-2003).  This new tool in development was a 9-item 
Likert scale that elicited three dimensions of communication: communication satisfaction, ease 
of communication and success of communication.  The lower the score the greater the 
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communication status.  Scores ranged from 0-36.  The time to complete this instrument ranged 
from 5 to 8 minutes.  In addition, the survey collected information about the method(s) of 
communication used by the respondents.   
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4.5 JUSTIFICATION OF SAMPLE SIZE 
This preliminary study was done to test the feasibility of a future study to establish effect 
size.  The effect size will be used to establish the sample size needed to ensure adequate power 
for a future study to determine patient preference.  Subjects were 30 patients who had 
experienced PMV (> 7 days) and tracheostomy and discharged from a high acuity ICU.   
 
4.6 PROCEDURES FOR DATA COLLECTION 
4.6.1 Recruitment Process 
The study was explained to the staff of the participating units, including inclusion criteria.  
The researcher contacted staff to inquire about status of potential participants.  Brochures were 
given to the staff to present to potential participants.  If the patient expressed interest in study 
participation:  
 a.  the patient was instructed to contact a member of the research team directly for 
additional information (See request for screening waiver below). 
 b.  medical/nursing staff members who were not study investigators obtained IRB 
approved written authorization from the patient to: 1) share with the research team that he/she 
was interested in study participation; 2) share with the research team health information related 
to eligibility for study inclusion; and 3) allowed a member of the research team to contact the 
patient to further inform them about the study or 
              c.  a medical/ nursing staff member who were study investigator reviewed the subject’s 
health information to determine if the subject was eligible for study entry. 
Screening Waiver: The PI requested IRB approval of a waiver of informed consent for 
screening to determine if potential participants entry criteria.  This screening waiver applied to 
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any potential participants/family members who called the PI directly regarding their interest in 
the study.  IRB criteria for granting this waiver was:  1) the respective research procedures 
presented no more than minimal risk of harm to the involved subjects; and 2) the information 
obtained during the screening phone call related to care normally required after admission to an 
intensive care unit, i.e., support with mechanical ventilation, tracheostomy, etc.  A screening 
script was used for these phone calls.  If the subject did not meet inclusion criteria, all 
information collected during the screening process was destroyed.     
Investigator Waiver:  The PI requested a waiver of informed consent/HIPAA 
authorization before a medical record review of the patient’s chart for inclusion/exclusion criteria 
was conducted by medical/nursing staff members who were directly involved in the health care 
of the potential research subject and also research team members.  Through this waiver, 
medical/nursing staff members were permitted to access protected health information to 
determine if the potential research subject qualified for study entry.   Access to patient protected 
health information by these research team members involved no more than minimal risk to the 
privacy of the patient.   
To ensure that the risk to privacy of the involved patient was minimal, any identifiable 
protected health information collected for the purpose of identifying potential subjects was stored 
in a secure manner (e.g., locked file and password protected database) accessible only to the PI 
and destroyed immediately after determining whether the patient qualified to participate in this 
research study.  Any information recorded for the purpose of identifying patients for recruitment 
into this study was not used by or disclosed to any research study investigator who was not also 
directly involved in the care of that involved patient.  Also, this information was not reused or 
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disclosed to any other person or entity, except as required by law or for authorized oversight of 
the research study. 
4.6.2 Administration of study instruments 
 
Questionnaires to assess Patient Preference for MV , QoL (SF-36v2), physical functioning 
(HAQ), depressive symptoms (CES-D), and communication status (PCS) were administered to 
participants in this order.  All tools were administered verbally.  A laminated card was presented 
to the patient to select answers.  No proxy responses were used. 
Table 4 Study instruments 
 Instrument Variables Data Sources 
1 Demographic Information 
Questionnaire 
Age, gender, 
etc. 
Chart 
2 Clinical Information 
Sheet 
Diagnosis, 
Apache, 
comorbidities, 
etc. 
Chart 
3 SF-36 QOL Patient 
4 HAQ Physical functioning Patient 
5 Communication Communication status Patient 
6 CES-D Symptoms of depression Patient 
7 Preference MV Preference Patient 
 
 
4.7 DATA ANALYSIS 
A process for data management was implemented to ensure accuracy and completeness 
of data collection and recording on a case-by-case basis via proof reading and the generation of 
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descriptive statistics with graphical representation of the variables prior to data analysis.  The 
descriptive statistics included mean, standard deviation, range and contingency checking.  There 
was no missing data. 
The underlying assumptions of the statistical procedures to be done were assessed.  If 
there were violations of the assumptions, such as lack of independence of observations, non-
normality, non-linearity, and homoscedasticity, data transformations were performed as 
appropriate and re-evaluated.  
For all statistical tests (correlations, partial correlations, 2 group t tests, and Wilcoxon 
Rank Sum test), a p-value of less than 0.05 was selected apriori to indicate statistical 
significance.   
Descriptive statistics were done to describe the sociodemographic, clinical 
characteristics, communication status, physical functioning, quality of life, depressive 
symptomatology, and preference characteristics of the sample.  Frequency distributions and 
proportions were used for categorical data and measures of central tendency, including mean, 
median, range, and standard deviation, were analyzed for continuous variables.  The non-
parametric Wilcoxon Rank test for non-normally distributed variables and the two-group t test 
for normally distributed variables was conducted to compare the groups – preferred vs. not 
preferred.    
 
4.8 LIMITATIONS 
The limitations of this study included: 
Only one health system and geographic area was used to recruit participants. 
Data was only collected at one time period.  
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The participants recruited included those living at the time of the study. 
Those cognitively impaired were not included. 
Only one method of addressing preference was used.  There may be a more effective method, 
such as a qualitative approach. 
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5 RESULTS AND DISCUSSION 
(Presented in Manuscript format) 
5.1 INTRODUCTION 
Care in the intensive care unit (ICU) is associated with significant costs and critically ill 
patients who require prolonged mechanical ventilation (PMV) account for a substantial 
proportion of these costs (Heyland et al, 1998). Although most individuals who require 
mechanical ventilation (MV) during an acute illness are quickly weaned from ventilatory 
support, a minority, estimated at 3 to 6% of all patients admitted to the ICU, require prolonged 
weaning (Rudy et al, 1995; Douglas et al, 2001). The cost of caring for patients who are difficult 
to wean is related to the time and effort-intensive nature of the weaning process, extended stay in 
acute and long-term care facilities, and the morbidity associated with increased time on the 
ventilator (Clochesy et al, 1997). 
In addition to the high costs associated with treatment, a prolonged ICU stay is associated 
with a high mortality. In studies conducted within the past 5 years, mortality rates for patients 
who require PMV ranged from 43% at 2 months after hospital discharge to 67 at 6 months after 
hospital discharge (QOL-MV, 2002; Seneff et al, 2000; & Douglas et al, 2002). Higher mortality 
was associated with increased severity of illness, increased age, and poorer physical functioning 
before hospitalization (QOL-MV, 2002). Further, the need for PMV is an indication of increased 
severity of illness and prolonged recovery trajectory (Douglas et al, 2001).  
Another outcome of prolonged critical illness is decline in physical functioning and subsequent 
need for an extended stay in long-term care facilities. Although one study reported that the 
majority of patients were independent in several daily activities, such as bathing, dressing, 
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feeding, and walking from room to room, at six months following ICU discharge (Niskanen et al, 
1999), most studies report a decline in physical functioning (QOL-MV, 2002; Chelluri et al, 
1995; Wissam et al, 2001). In a prospective study that enrolled 817 patients who required MV 
for ≥ 48 hours, Chelluri et al. (2002) found that patients’ physical functioning was worse at 2 
months following ICU discharge compared to before hospital admission. Hoffman, et al (2003) 
reported that only 20% of patients were discharged to home 1-month following ICU discharge 
and 39% at 4-months after discharge in a prospective study that enrolled 80 patients who 
required MV for ≥ 7 days.   
Most studies examining outcomes following PMV have focused on physical functioning, 
quality of life (QoL), morbidity, mortality and the care giving experience.  Patient preferences 
regarding PMV have rarely been explored (Mendelsohn et al, 2002).  Of studies that examined 
preferences, most were anticipatory in nature. Patients were asked about future end-of-life 
decision-making, use of advanced directives, or treatment preferences for conditions likely to 
require MV such as end-stage chronic obstructive pulmonary disease (COPD), amyotrophic 
lateral sclerosis, and muscular dystrophy (Tilden et al, 1995; Hoffman et al, 1997; & McKinley 
et al, 1996). It is unclear whether an individual who have experienced an episode of acute illness, 
including PMV, would have the same preferences as verbalized before the event (Mendelsohn et 
al, 2002). In order to fully examine preferences, it is important to elicit this information from 
individuals who undergone this experience and, therefore, have first hand knowledge of its 
impact.   
In one of the few studies to examine preferences in ICU patients, Teno and colleagues 
(2000) interviewed 1494 patients who had been admitted to the ICU for ≥ 14 days (median 35 
days) or their surrogate decision makers and physicians to determine how frequently prognosis, 
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preferences, and goals of medical care were discussed. Although 55% of these patients died 
within 6 months and those surviving had a significant functional impairment, only 34% of 
patients or surrogates had discussed preferences with their physicians by the second week of 
hospitalization.  In a second study of patient preferences, Mendelsohn et al. (2002) interviewed 
133 survivors of PMV (> 48 hours; median 8 days) 12 months after ICU discharge and found 
that most (86.5%) would elect to undergo MV again. However, a substantial proportion of the 
original sample died (43% at 2 months) and 21% were lost to attrition (QOL-MV, 2002). In 
addition, PMV was defined as > 48 hours, whereas the more common definition is > 7 days 
(Seneff, 2000; Wissam et al, 2001; & Phelan, 2002). 
There are a number of factors that might influence patient preferences regarding MV 
including its potential impact on ability to regain previous level of physical functioning, QoL, 
communication status, and depression. Survivors of PMV have been shown to have decreased 
QoL compared with the general population (Chatila et al, 2001). Nasraway et al (1999) described 
the outcomes of 97 survivors of prolonged critical illness (median ICU stay 39 days). One year 
later, only 11.5% of these patients were weaned from MV, had returned home and reported a fair 
or better quality of life, and good physical functioning. Communication status may also impact 
patients’ preferences regarding MV, but this aspect of functioning has received little examination 
(Happ, 2001). Initially, MV is provided with an endotracheal tube, which eliminates the ability to 
speak. Extended use of an endotracheal tube, especially for periods > 7 days, may result in 
hoarseness (41-71% of patients), vocal cord immobility (19%), and laryngeal stenosis (0-5%), 
resulting in impaired speech (Stauffer, 1999). To minimize risk and promote patient comfort, a 
tracheostomy is typically performed after 7-10 days of MV if the patient is unable to wean from 
MV or has problems managing airway secretions (Heffner, 1993). However, the need for a 
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tracheostomy may also compromise patient ability to communicate, especially if a cuffed tube is 
required (Orringer, 1999). Although augmentative communication methods can be used, e.g., 
paper and pencil, tracheostomy tubes with speaking valves, and computer keyboards, such 
devices are infrequently and inconsistently used in the ICU setting (Happ, 2001). Recovery 
typically continues long after ICU discharge, an outcome which can increase risk for depression.  
In the QOL-MV study (2002), 35% of 232 patients who required MV > 48 hours had 
symptoms of depression 2 months following hospital discharge. Further study is indicated to 
better define patient preferences for the significant and growing population of chronically 
critically ill patients who require PMV.  
The purpose of this study was to elicit preferences regarding MV in patients who 
received PMV and tracheostomy and characteristics associated with these preferences.  The 
specific aims were to examine relationships between MV preference and selected potential 
influencing factors including demographics, clinical characteristics, QoL, functional status, 
depressive symptomatology, and communication status and identify factors influencing these 
preferences.   
 
5.2 METHODS 
5.2.1 Site and Sample 
 
Subjects were recruited from a university-affiliated tertiary care institution located in 
southwestern PA (n=9) and six long-term care referral sites (n=21) during a 5-month interval 
(3/2004 – 7/2004). The referral sites included three long-term acute care (LTAC) hospitals and 
three skilled nursing facilities.  Entry criteria were: 1) >18 years of age; 2) on MV for ≥ 7 days; 
3) tracheostomy during this admission; and 4) able to understand English (required to answer 
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questionnaires); and 5) cognitively intact as determined by a standardized score of > 24 on the 
Mini-Mental State Examination (MMSE) (Folstein et al, 1975). The study received Institutional 
Review Board approval and all subjects provided informed consent.   
5.2.2 Design 
Each subject answered 5 questionnaires to assess: 1) preferences toward MV for actual and 
hypothetical situations (Mendelsohn et al, 2002); 2) quality of life (Medical Outcomes Study 
[MOS] Short Form [SF]-36v2) (Ware et al, 2000); 3) physical functioning (Health Assessment 
Questionnaire [HAQ] (Fries et al, 1980); 4) depressive symptoms (Center for Epidemiological 
Studies Depression Scale [CES-D] (Radloff, 1977); and 5) communication status (Patient 
Communication Survey [PCS] (Happ, Roesch, Kagan, 2001-2003).  The instruments were 
completed in the order listed during an interview session scheduled a minimum of 6 weeks 
(range 6 to 362.6 weeks) after the subject had been on MV for ≥ 7 days and received a 
tracheostomy.  One investigator obtained all study data.  The interview took place in the patients’ 
room and lasted approximately 1.5 hours.  All tools were administered verbally.  A laminated 
card was presented to the patient to select answers.  No proxy responses were used. 
5.2.3 Instruments 
Preferences Toward MV were assessed using an instrument designed to elicit preferences 
toward MV from critically ill patients who received MV in an ICU (Mendelsohn et al, 2002).  
When completing this portion of the study, subjects were first asked if they would choose MV 
again (yes/no) in view of their experience. They were then asked to rate five domains associated 
with their ICU and post-ICU experience: 1) present health state; 2) pain or discomfort from MV; 
3) pain or discomfort in the ICU; 4) perceived family financial burden from hospitalization, and 
5) perceived family emotional and physical stress (caregiver burden) from hospitalization using a 
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5-point Likert scale that ranged from 0 (positive, i.e., excellent health, no pain/discomfort) to 4 
(negative, i.e., poor health, extreme pain/discomfort) (Appendix A 3). To reduce order effects, 
patients were given the opportunity to change their responses after answering all five questions.  
If a response was changed, the new answer was recorded.  If the subject did not recall being in 
the ICU, MV or aspects of the experience (pain/discomfort), the response was coded as having 
“no pain/discomfort”. 
After these ratings were recorded, subjects were asked to identify changes in each of the 
domains that would alter their preference regarding MV.  Each of the five domains was 
manipulated individually (holding the levels of the other four domains constant) until the subject 
changed his/her preference. As an example, a subject who indicated that he/she would have 
chosen MV again was asked if a more negative experience in regard to his/her present health 
state, pain/discomfort from MV, pain/discomfort in the ICU, etc. would alter this preference. 
Conversely, a subject who indicated he/she would not choose MV again was asked if a more 
positive experience in regard to each domain would alter this preference. Each subject was 
questioned regarding changes in his/her preference until he/she indicated a point between two 
consecutive points along the 5-point scale where this preference changed.  This was termed the 
indifference point; i.e., the point at which there was no preference between the two alternatives 
(MV or no MV).  Subjects whose preference did not change for any scale value were deemed to 
have no indifference point for that factor. 
Demographic data included age, gender, ethnicity, education, employment prior to 
hospitalization, occupation, marital status, and insurance type. Clinical data, obtained from the 
medical record, included primary diagnosis, comorbidities (Charlson Comorbidity Score) 
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(Charlson, Pompei, Ales & MacKenzie, 1987), ICU and hospital length of stay, indication for 
MV, date of intubation and tracheostomy, weaning status and decannulation status.   
QOL was measured with the SF-36v2 (Ware et al, 2000).  The SF-36 was developed as a 
generic measure of physical functioning and well being. It was comprised of eight subscales: 
physical functioning, role functioning, bodily pain, general health, vitality, social functioning, 
mental health, and reported health transition. Scores on four subscores (physical functioning, role 
functioning, bodily pain, and general health) were combined to yield a physical component score 
and scores on the remaining four subscales (vitality, social functioning, mental health, and 
reported health transition) combined to yield a mental component score. The total score ranged 
from 0-100, with higher scores indicating greater QOL and general health. Reliability 
coefficients equal or exceed 0.80 (Ware et al, 2000).  Internal consistency and item discriminate 
validity equals or exceeds 0.40 (Ware et al, 2000). The SF-36 has been used successfully with 
individuals with both acute and chronic illnesses, including individuals experiencing MV 
(Eddleston et all, 2000).  Time to completion ranged from 15 to 20 minutes. 
Physical Functioning was measured using the HAQ (Fries et al, 1980). The HAQ was 
developed to evaluate physical functioning for patients with rheumatoid arthritis. The tool 
quantified eight general constructs (dressing, grooming, arising, eating, walking, hygiene, reach, 
grip, and outside activity with 18 items that were scored using the scale 0=without any difficulty, 
1=with some difficulty, 2=with much difficulty, 3=unable to do, and an item about use of aids or 
devices, such as a cane or wheelchair or help from another person.  The highest score on any 
question within the subdomain was used as the score for that subdomain. A point is added when 
the individual needs to use a disability aid.  The total score was determined by adding subdomain 
scores and dividing by the total number of subdomains completed. Scores ranged from 0 to 3, 
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with higher scores indicating greater functional impairment.  Internal consistency estimates 
ranged from 0.71 (Milligan et al, 1993) to 0.94 (Pincus et al, 1983). Two-week test-retest reliability 
estimates ranged from 0.87 to 0.98 (Fries et al, 1982). In 32 patients with COPD, 2-week test-retest 
reliabilities ranged from 0.972 to 0.975 (unpublished data). Validity has been assessed by 
examining relationships with the Functional Status Index (r=0.75) and the Sickness Impact Profile 
(r=0.78) (Liang et al, 1985). Time to completion ranged from 3 to 8 minutes. 
Depressive symptomalogy was measured using the CES-D (Radloff, 1977). The CES-D was 
a 20-item Likert scale, which assessed depressed mood, feelings of guilt and worthlessness, 
helplessness and hopelessness, loss of appetite, and sleep disturbances. The total score ranged 
from 0 to 60, with scores of > 16 suggesting risk of clinical depression. Coefficient alpha ranged 
from 0.84-0.90 (Radloff, 1977).  Time to completion ranged from 10 to 15 minutes. 
Communication status was evaluated using the Patient Communication Survey (PCS).  The 
PCS was a 9-item Likert scale that measured three dimensions of communication: 
communication satisfaction, ease of communication and success of communication (Happ et al, 
2001-2003). The total score ranged from 0 to 36, with lower scores indicating greater ability to 
communicate.  Time to completion ranged from 5 to 8 minutes.  In addition, the survey collected 
information about the method(s) of communication used by the respondents.   
Cognitive functioning was assessed with the Mini Mental State Exam (MMSE) (Folstein et 
al, 1975).  The MMSE was an 11-question general-purpose cognitive screening examination that 
examined the concepts of orientation, registration, attention and calculation, recall, and language 
to quantify severity of cognitive impairment in persons with dementia or dementia-like 
conditions (Foreman, 1987). Time to completion ranged from 5 to 10 minutes.  A score of < 24 
indicates cognitive impairment and excluded study entry. 
  83
5.3 DATA MANAGEMENT AND ANALYSIS 
A process was implemented to ensure accuracy and completeness of data collection and 
recording on a case-by-case basis via proof reading and the generation of descriptive statistics 
with graphical representation of the variables prior to data analysis. There were no missing data. 
However, one subject was unable to state a preference for MV despite prompting and time for 
contemplation. Responses from this individual were therefore not included in the analysis of 
preferences and influencing factors.   
Statistical analysis of all variables included descriptive statistics. Categorical variables, 
such as gender, race, level of care, and marital status were analyzed using Pearson Chi-Square 
and Fisher’s Exact Test, when the expected cell count was less than 5. Continuous variables, 
such as the SF-36, HAQ, CES-D, and PCS scores, were examined using two-group independent t 
test for normally distributed variables and non-parametric Wilcoxon Rank Sum test for non- 
normally distributed variables.  Statistical analysis was performed using SPSS (version 11.5). A 
p-value of less than 0.05 was selected a priori to indicate statistical significance. 
 
5.4 RESULTS   
5.4.1 Demographic Characteristics 
Thirty patients (17 male, 13 female) aged 62.7 + 17.6 years (range 20-83 years) were 
enrolled in this study (Table V).  With one exception, all were Caucasian (n=29, 96.7%). The 
group was included subjects who were married (n=13; 43.3%), single (n=7; 23.3%) and 
widowed or divorced (n=10; 33%). Most subjects had less than a high school education (n=19; 
63.3%). However, the sample included 10 subjects with education beyond high school, including 
one nurse, one dentist and two attorneys. Most were not employed (n=18; 60%) at the time of 
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their hospitalization.  The sample was evenly divided between those who were insured by 
Medicare (n=15; 50%) and other payors. The reason for admission included medical (n=15; 
50%), surgical (n=12; 40%), and trauma (n=3; 10%) related diagnoses.   
At the time of data collection, 17 subjects were on MV with a tracheostomy, including 
five subjects who remained in the ICU. Eight were in a long-term acute care facility and 
continued to participate in weaning trials.  Four were in skilled nursing facility with no further 
weaning attempted because of a diagnosis of neuromuscular disease or chronic obstructive 
pulmonary disease (COPD).  One subject was discharged home on nocturnal ventilation 
secondary to COPD and sleep apnea.   
5.4.2 MV Preference 
Of the 29 subjects, most (75.9%) stated they would elect to under go MV again (Table VI).  
Insurance status was significantly associated with MV preference (p = .023).  Subjects not 
insured by Medicare were more likely to state that they would undergo MV again. Other 
demographic variables, including age, gender, residence in an acute care, long term acute care or 
skilled nursing facility, marital status, education, employment, diagnosis and current 
airway/ventilator support were not significantly associated with MV preference.  
When trends were examined, subjects admitted to a LTAC indicated a strong preference for 
undergoing MV again (yes=9; 1=no), as did subjects admitted to a SNF (yes=8; no=2). Subjects 
hospitalized in an acute care institution, including those in an ICU, were more evenly divided 
regarding whether they would undergo MV again (yes=5; 4=no). All single respondents 
indicated that they would undergo MV again (yes=7), whereas those who were married (yes=9; 
no=3) or widowed/divorced (yes=6; no=4) were more varied in their choices. Subjects who had 
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more than a high school education were also more likely to state that they would undergo MV 
again (yes=9; no=1).   
The number of days to tracheostomy ranged from 0 to 27 days (median 7) for the yes group 
and 6-20 days (median 9) for the no group (Table VII).  Median ICU LOS compared closely for 
subjects who stated they would and would not undergo MV again (yes=31 days; no=27 days), 
but there was considerable variation in the range of days each group spent in the ICU (yes=7–
186 days; no=14-83 days). The median hospital LOS was also similar for both groups (yes=31 
days; no=29 days). Again, there was considerable difference in range of days in the hospital 
(yes=7-205 days; no=14-83 days).  The number of MV days varied extensively because 6 of the 
SNF subjects had been on MV for several years.     
Scores on the CES-D differed, albeit not significant (p=.051), with higher median scores  
for those who would have chosen MV versus those who would not have chosen MV (29 and 14 
days, respectively). Many subjects enrolled in the study were being treated for depression, but 
most (56.67%) continued to display symptoms of depression as demonstrated by CES-D scores.  
Scores on instruments measuring QOL and functional ability did not differ in regard to those 
who would and would not undergo MV again.  There were also no significant between group 
differences in scores measuring communication ability.   
5.4.3 Hypothetical Scenarios 
Of the 22 subjects who would choose MV again, a majority, consisting of 12 to 14 subjects, 
did not achieve an indifference point, i.e., their preference remained unchanged regardless of 
domain manipulation (Table 4). The remaining subjects changed their preference after 
manipulation of domain scales (n=6 to 7) or were unable identify an indifference point (n=1 to 
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3). Preference tended to be more likely to change if the domain involved the family’s emotional 
and physical stress and the family’s financial burden.     
For the 7 subjects who indicated that they would not choose MV again, preference tended 
to be most stable in regard to pain/discomfort in the ICU. A variable number, ranging from 1 to 3 
subjects, changed their preference after manipulation of the remaining domain scales. Preference 
was most likely to change in reference to present health status and the family’s financial burden, 
the family’s emotional and physical stress.  
Table 5 presents characteristics of the 7 subjects who indicated they would not choose MV 
again and the subject who was undecided.  With the exception of coverage by Medicare, there 
appeared to be no consistent characteristics that distinguished these individuals.    
5.4.4 Effect Size 
Because the sample size was small, effect size was calculated to provide an estimate of the 
adequacy of the sample. Effect size was highest for the CES-D (d=0.793), with lower values for 
the HAQ (d=.548), PCS (d=0.424), SF-36 physical (d=.166) and SF-mental (0.094). Thus, the 
study appeared adequately powered to detect the influence of depression and functional ability 
on preference for MV, but inadequately powered to detect differences in QOL or ease of 
communication. 
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Table 5  Demographics of Sample 
Variable n(%) 
(n=30) 
Age, years (mean + SD) 62.7 + 17.6 
Gender, % male 17 (56.7%) 
Race 
     Caucasian 
     African-American 
 
29 (96.7%) 
1 (3.3%) 
Marital Status 
     Married 
     Widowed/Divorced 
     Single 
 
13 (43.3%) 
10 (33%) 
7 (23.3%) 
Educational Level 
     < High School 
     > High School 
 
19 (63.3%) 
11 (36.7%) 
Employment 
     Working  
     Not working 
     Other 
 
5 (16.7%) 
18 (60.0%) 
7 (23.3%) 
Insurance  
     Medicare  
     Other 
 
15 (50%) 
15 (50%) 
Preference for MV  (Yes) 22 (73.3%) 
Diagnosis  
     Medical 
     Surgical 
     Trauma 
 
15 (50.0%) 
12 (40.0%) 
3 (10.0%) 
Airway/ventilator support 
     (at interview) 
     MV with tracheostomy 
     Tracheostomy 
     No MV or tracheostomy 
 
 
17 (56.7%) 
8 (26.7%) 
5 (16.6%) 
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Table 6  Association of patient demographics and preference for MV 
Variable 
Preference for MV 
(Yes) 
(n=22) 
Preference for MV 
(No) 
(n=7) 
 
P value 
 
Age, years 60.8 (19.2) 
20-81 
67 (11.7) 
45-83 0.432 
Gender, % male 13 (59.1%) 3 (42.9%) 0.452 
Race 
   Caucasian 
   African-American 
 
21 (95.5%) 
1 (4.5%) 
 
7 (100%) 
0 
 
0.566 
Level of Care 
   Acute Care 
   LTAC 
   SNF 
 
5 (22.7%) 
9 (40.9%) 
8 (36.4) 
 
4 (57.1%) 
1 (14.3%) 
2 (28.6%) 
 
0.201 
Marital Status 
   Single 
  Married 
  Widowed/Divorced  
 
7 (31.8%) 
9 (40.9%) 
6 (27.2%) 
 
0 
3 (42.9%) 
4 (57.2%) 
0.157 
Education Level 
  < High School  
   > High School 
 
13 (59.1%) 
9 (40.9%) 
 
6 (85.7%) 
1 (14.3%) 
 
0.197 
Employment 
  Not Working  
  Working 
  Disabled 
 
11 (50.0%) 
5 (22.7%) 
6 (27.3%) 
 
6 (85.7%) 
0 
1 (14.3%) 
 
0.210 
Insurance 
  Medicare  
  Other 
 
8 (36.4%) 
14 (63.6%) 
 
6 (85.7%) 
1 (14.3%) 
0.023 
Diagnosis 
Medical 
Surgical 
Trauma 
 
10 (45.5%) 
9 (40.9%) 
3 (13.6%) 
 
4 (57.1%) 
3 (42.9%) 
0 
 
0.574 
Airway/ventilator support 
(at study completion) 
MV with tracheostomy 
Tracheostomy 
No MV or tracheostomy 
CTB 
 
8 (36.4%) 
3 (36.4%) 
9 (40.9%) 
2 (9.1%) 
 
2 (28.6%) 
0 
5 (71.4%) 
0 
0.439 
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Table 7 Association of clinical patient data and preference for MV 
Variable 
 
Median (Range) 
Preference for MV 
(Yes) 
(n=22) 
Preference for MV 
(No) 
(n=7) 
 
P value
 
Days to tracheostomy 7 
(0-27) 
9 
(6-20) 0.672 
ICU LOS 31 
(7-186) 
27 
(14-83) 0.539 
Hospital LOS 31 
(7-205) 
29 
(14-83) 0.554 
MV Days 98.5 
(8-2624) 
70 
(10-1668) 0.886 
Tracheostomy Days 102 
(21-2624) 
64 
(18-1662) 0.837 
Charlson 4 
(0-13) 
5 
(0-7) 0.522 
Mini-mental1 
(< 24 excluded from study) 
28 
(24-30) 
28 
(26-30) 0.832 
SF-36 Physical1 
 
22.48 
(13.3-36.9) 
25.89 
(20.2-43.7) 0.145 
SF-36 Mental1 
 
48.5 
(19.1-65.6) 
59.5 
(36.2-71.2) 0.226 
HAQ2 
 
2.56 
(0.04-3.00) 
2.8 
(1.7-3.0) 0.447 
CES-D2   (> 16 indicates symptoms 
of depression) 14 
(2-41) 
 
29 
(9-49) 
0.051 
Communication2  21.5 
(6-32) 
20.0 
(8-24) 0.423 
1 = higher scores = better cognition, & QOL 
2 = lower scores = better functionality, depression, communication 
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Table 8  Factors Influencing a Change in Patient Preference for MV* 
Domain Change in Preference 
Would choose 
MV 
(n=22) 
Would not  
choose MV 
(n=7) 
    
No change in preference 14 3 
Unable to decide 1 1 
Present health 
status 
Change in Preference 
Excellent → very good 
Very good → good 
Good → fair 
Fair → poor 
 
0 
0 
1 
6 
 
2 
1 
0 
0 
    
No change in preference 14 6 
Unable to decide 1 0 
Pain/discomfort 
from MV 
Change in preference 
Excellent → very good 
Very good → good 
Good → fair 
Fair→ poor 
 
0 
0 
3 
4 
 
1 
0 
0 
0 
    
No change in preferences 14 3 
Unable to decide 2 2 
Pain/discomfort 
from ICU 
Change in preference 
Excellent →very good 
Very good →good 
Good →fair 
Fair → poor 
 
0 
0 
4 
2 
 
1 
1 
0 
0 
    
No change in preference 12 3 
Unable to decide 3 1 
Family’s 
financial burden 
Change in preference 
Excellent → very good 
Very good → good 
Good → fair 
Fair → poor 
 
0 
1 
3 
3 
 
3 
0 
0 
0 
    
No change in preference 13 3 
Unable to decide 2 1 
Family’s 
emotional and 
physical stress 
Change in preference 
Excellent → very good 
Very good → good 
Good → fair 
Fair → poor 
 
0 
0 
1 
6 
 
3 
0 
0 
0 
 * Data presented for subjects with complete responses to all items in domain 
  
 
Table 9  Characteristics of subjects who would not have chosen MV (n=7) or did not indicate a preference (n=1) 
Definition of abbreviations: M= male, F= female, SNF= skilled nursing facility, AC= acute care, LTAC= long term acute care, 
Age Gender LOC Ventilation Status Diagnosis Insurance 
MV 
days 
Pain/ 
Discomfort 
in ICU or 
on MV 
CES-
D 
Score
SF36 
Score 
(PC) 
SF36 
Score  
(MC 
HAQ 
Score 
Communication  
Method 
 SUBJECT UNDECIDED ABOUT CHOOS ING MECHANICAL VENTILATION AGAIN 
74 M SNF Spontaneous Guillian Barre 
 
MC & Co-Pay 33 Undecided 19 36.17 50.53 3.00 Speaks Capped trach 
                S UBJECTS WHO STATED THEY WOULD NO CHOOS E MECHANICAL VENTILATION AGAIN 
65 M SNF MV with tracheostomy  COPD MC/MA 1668 No (both) 18 23.40 59.51 1.96 
Writes & mouths 
words 
65 F AC MV with tracheostomy 
End stage 
liver disease MC & Co-Pay 149 No (both) 33 25.89 36.33 2.88 
Writes & mouths 
words 
72 F AC Spontaneous Postoperative Complications MC & Co-Pay 10 
ICU 
undecided/ 
No 
26 16.95 45.02 3.00 Mouths words 
45 F LTAC Spontaneous 
Acute 
respiratory 
failure 
SSDI 12 Undecided 49 20.81 20.26 2.73  Speaks 
74 M SNF Spontaneous 
Acute 
respiratory 
failure 
MC & Co-Pay 160 Yes (both) 9 19.25 58.64 1.69 Speaks 
65 F AC MV with tracheostomy 
Postoperative 
Complications MC only 70 No (both) 43 25.97 28.47 2.81 Mouths words 
83 M AC Spontaneous Pancreatitis MC & Co-Pay 23 Yes (both) 29 26.10 48.11 3.00 Fenestrated trach 
 
MC= Medicare; MA = medical assistance; PC = physical component SF-36; MC – mental component SF-36. 
5.4.4.1.1.1  
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5.5 DISCUSSION 
We evaluated preferences toward MV among patients who received PMV and 
tracheostomy. The major findings of this study were: 1) cognitively intact survivors of prolonged 
MV and tracheostomy choose MV even though 17 remained dependent on MV at the time of 
interview; 2) patients with non-Medicare insurance were significantly more likely to have chosen 
MV; and 3) survivors experiencing fewer symptoms of depression displayed a strong trend 
toward being more likely to have chosen MV. 
Healthcare providers have an obligation to elicit patient preferences toward life 
sustaining treatments to order to individualize their care.  This is especially true in settings such 
as the ICU where some treatments, such as MV, can be viewed as artificial life support. Many 
patients admitted to the ICU have conditions associated with a high mortality, severe functional 
deficits, and an extended recovery. With patient and family input, the healthcare team may 
choose a plan of care that emphasizes comfort and pain relief, rather than life-sustaining 
measures, to accommodate patient preferences.   
Patients are routinely asked about their preferences as they relate to advanced directives 
when they are admitted to a hospital.  Advanced directives are preferences for healthcare 
determined by an individual while he or she has decisional capacity about medical treatment he 
or she would or would not like to receive in the event that decisional capacity is lost (Ahronheim 
et al, 2000).”  Sometimes those preferences or advance directives are written in the form of a 
living will or individuals may identify a durable power of attorney for health care.  In a living 
will, a person requests that, if they become disabled beyond reasonable expectation of recovery, 
decisions about care that were made a priori be followed.  This is a powerful method to 
document preferences. However, individuals commonly make advance directives based on 
sources other than experience. The use of MV is considered an extraordinary measure and, as 
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such, is often included in a living will, along with treatments such as blood transfusions, tube 
feedings, and antibiotics.  With very few exceptions, the individual writing a living will is likely 
to never have experienced MV, let alone PMV and tracheostomy. 
Most studies that have examined recovery following PMV report that patients require a 
long period of time to regain their prior physical functioning, or never regain this ability 
(Mendelsohn et al, 2002, Teno et al, 2000, Danis et al, 1988, & Elpern et al, 1992).  
Consequently, the personal and economic cost of a critical illness and extended recovery 
trajectory is substantial. Often care is provided in a setting designed to provide a lower level of 
care, e.g., long-term acute care, acute rehabilitation, or skilled nursing facility. This recovery 
period may be followed by home care and outpatient services to help the person return to optimal 
health and functioning. Some patients spend the remainder of their life in a facility dependent for 
assistance with activities of daily living.  When individuals become dependent on others for care 
at home or in an institution, there is a high cost to the family in lost wages, stress and anxiety. 
Regardless of these issues, findings of this study suggest that the majority of cognitively 
intact patients would elect to undergo MV, if given the opportunity to make this choice. In the 
present study, 76% of patients indicated a preference for MV. Those indicating a preference for 
MV spent an extended period of time on in the ICU (median 31 days) and on MV (median 99; 
range 8-2624 days), as did those who did not indicate a preference for undergoing MV.  In fact, 
the duration of time in the ICU (median 27 days) was very similar and time on MV slightly less 
for those who would not elect MV (median 70 days; range 10-1668 days). Therefore, neither the 
duration of time on MV or time in the ICU appeared to influence patient preferences.  A 
significant difference between groups was found for insurance status, with those preferring MV 
less likely to have Medicare as their insurance provider. The explanation for this finding is not 
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clear, as age did not differ significantly between preference groups. It is possible that individuals 
who were insured by Medicare had less extensive benefits, but we did not examine this potential.  
Patients who had fewer symptoms of depression tended to be more likely to indicate a 
preference to undergo MV again, but this finding did not reach statistical significance. 
Unexpectedly, there were no significant differences in scores on instruments measuring 
functional ability, QoL, or communication status.  Likely, this was due to the limited sample size 
and consequently limited statistical power for instruments measuring QoL, functional ability, and 
communication status, as indicated by effect size. 
Findings of the present study support those of Mendelsohn et al. (2002) who used the 
same instrument to assess preferences at 12 months post ICU discharge in patients who had been 
on MV for > 48 hours (median 8.6 days). Of 133 patients interviewed, 87% would have chosen 
MV, with younger (< 65 years old) patients (90% vs. 68%; p = 0.0006) and healthier (92.5% vs. 
77.4%, p = 0.01) patients more likely to have chosen MV compared to older and sicker patients.  
It is interesting to note that, although the time at which interviews were conducted varied 
between the two studies, the proportion of patients electing to choose MV again was similar. 
When change in preferences was examined in regard to the hypothetical scenarios, 
Mendelsohn et al (2002) reported that 25% of those who would have initially chosen indicated 
they would refuse this therapy if their families’ financial burden were beyond certain thresholds. 
A similar proportion would have refused MV if it were associated greater pain or discomfort.  
This study showed that for individuals who would initially chose MV would refuse if their 
present health were poor and if the family’s stress was worse.  Patients who would not chose MV 
would change their mind if their family’s financial burden and stress were reduced.   
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Several additional studies have examined patient preferences for ICU care and life 
sustaining treatments.  In 1988, Danis et al. (1988) interviewed 160 patients and family members 
who were in a medical or respiratory ICU for at least 24 hours to determine preferences for ICU 
care and the importance of the life circumstances in determining those preferences.  Families 
were interviewed regarding decisions they would make for the hospitalized person if the patient 
was unable to participate.  Median ICU length of stay was 3-5 days and mean (+SD) APACHE II 
scores were: Group I = 13 + 7, Group II = 12 + 4, Group III = 16 + 6 (p<0.05), and Group IV = 
20 + 8 which indicates low acuity.  Most patients (74%, n=51) stated they would be “completely 
willing” to undergo ICU for very brief periods of life prolongation.  Family preferences were 
similar.  Patients (n=11) and families (n=17) would not choose ICU if there was no hope of 
recovery, if the patient would be kept alive by machines (n=7, n=10, respectively) and if the 
patient were vegetative or neurologically impaired (n=7, n=10, respectively).  These findings are 
similar to comments made by patients in the present study regarding preference being influenced 
by survival, cognitive ability and the need for tube feedings.     
In 1992, Elpern, et al. (1992) reported findings from a study of patient preferences 
following an ICU stay of ≥ 48 hours. Patients were evaluated within 48 hours of ICU discharge 
to determine eligibility (entry criteria required they be alert and oriented) and interviewed 
according to their availability and tolerance.  Most participants (96%) stated they preferred life 
support to restore their usual state of health.  As scenarios of declining functional and cognitive 
ability were presented, preference decreased.  In this study, the average ICU length of stay was 
relatively short (4.5 days), the mean APACHE II score (13.3) indicated low acuity, and all 
patients were breathing spontaneously.  However, preferences were similar to the present study. 
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In 2000, Teno et al. (2000) examined decision-making and outcomes following an ICU 
stay of ≥ 14 days in 1494 patients recruited from five ICUs who were enrolled in the SUPPORT 
(Study To Understand Prognoses and Preferences for Risks and Outcomes of Treatment) study. 
The patient or a family decision-maker was interviewed during the second week of 
hospitalization while most (91%) patients were still in the ICU.  Slightly less than half of 
patients/families (45%) preferred a life extending approach, while 36% expressed a preference 
for comfort, even if it shortened life. The authors did not distinguish between the preferences 
provided by patients or family members. However, it is likely that, because most of the patients 
were hospitalized in the ICU, family members would have been the primary information 
providers. Accordingly, it is not clear if their preferences were those of the patients. In the 
present study, patients, rather than proxies, provided all study data and those who were 
interviewed in the ICU consistently stated they would undergo MV again.    
No studies were found that examined the effect of communication status on preference 
for MV, ICU or life support.  All participants were cognitively intact and able to communicate.  
However, most expressed frustration with their ability to communicate as desired; one even said, 
somewhat jokingly, that his inability almost caused a divorce.   
 
5.6 LIMITATIONS 
This study was subject to several limitations.  First, the sample size was relatively small 
which limits the strength and generalizability of the findings. In particular, we had limited 
statistical power to find difference between the preference groups.  However, study findings 
were consistent with those of larger studies employing different and similar methods. Second, 
entry criteria required that patients be on MV for ≥ 2 months and have tracheostomy. However, 
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there was no restriction on the length of time on MV, which varied considerably for those 
enrolled in this study. It is possible that length of time on MV influenced patient preferences. 
However, median days on MV were longer for those who stated they would elect to receive MV.  
Finally, the sample only included cognitively intact survivors of PMV. It is possible that 
survivors who were unable to function at this level might have very different preferences. 
However, a goal of the study was to elicit preferences from the patients themselves, rather than 
proxies, which required they be able to understand questionnaire item and share their responses.   
 
5.7 CONCLUSION 
In summary, most cognitively intact patients who experienced PMV and tracheostomy 
would be willing to experience a repeat episode MV.  As one individual, so eloquently stated, 
“Of course, I would go on the breathing machine again – I’m alive.” Preference for MV 
increases if there would be a return to usual health, with a reduction in the number of people who 
prefer MV if it resulted in increase family stress and financial burden.  Those individuals who 
were insured by Medicare were less likely to choose MV and those with more depressive 
symptoms tended to also not indicate a preference for MV.  Although the effects of depression 
on preference for life support are understandable, the effect of Medicare was unclear because it 
was not a surrogate for age or disability.   
As critical care nurses, we often speculate on the wisdom, appropriateness, and 
effectiveness of life saving strategies.  We wonder about patient preferences.  The results of this 
study support the provision of resuscitation, including MV and tracheostomy for the chronically 
critically ill.  Further research is needed to explore preferences for PMV in situations where the 
outcome of survivors results in cognitive impairment and / or a vegetative state.   
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APPENDIX A.1 Demographic Information Sheet 
Study ID  ________________________________ 
 
Gender: Male  Female 
 
Date of birth:  __________   Age __________ 
 
Race:  _______ White          _______ African American 
           _______ Latino (Mexican/Latin American/Caribbean)    _______ American Indian 
           _______ Asian           _______ Other 
 
Insurance:  
 _______ Medicare only   _______ Medicare w/co-insurance 
 _______ Blue Cross    _______ HMO 
 _______ Medicaid    _______ None 
 _______ Other:  ______________________________________________ 
 
Highest level of education completed: 
 _______ Grade School (1-8)   _______ High School (9-12) 
 _______ High school graduate  _______ Earned GED 
 _______ Vocational/Technical School _______ 2-year college (AD) 
 _______ 4-year college (Bachelors)  _______ Graduate School (Masters) 
 _______ Professional School (MD, JD)  _______ Graduate School (PhD) 
 
Employment prior to hospitalization: 
 _______ Working full time   _______ Working part time  
_______ Retired, not working   _______ Retired, working 
 _______ Disabled/unable to work  _______ Full time homemaker 
 
 
Occupation: ______________________________________ 
 
Marital Status: 
 _______ Single (never married)   _______ Married 
 _______ Widowed     _______ Divorced 
 
Next of kin (for decision making): 
 Name _______________________________________________  
 
 Relationship _________________________________________ 
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APPENDIX A.2Clinical Information 
Date Hospital 
Admission 
Date ICU Admission Was there ICU 
readmission? 
Date ICU discharge 
Diagnosis 
Comorbidities 
 
Prime reason for vent (including precipitation factors) 
Brief history of ICU stay 
Any significant complications 
Date of intubation Episode of 
reintubation 
#Days intubated 
before trach 
Date of trach 
decannulation 
ICU LOS Hospital LOS ICU discharge 
location & date 
LOS 
Date weaned from 
vent 
Final f/u location   
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Appendix A3 Patient Preference Study  
 
1.  I would like to ask you about the decision to have a breathing tube. Still thinking about  
      that hospitalization, if you knew then what you know now about the whole experience,  
      would you have chosen to have the breathing tube?  
                                      
     ___1 Yes              0 No                 -3 Unknown            -4 Refused 
 
2.  I would like to probe further into your ICU experience.  (If necessary): I would like to  
conduct this part of the interview without anyone else present, if possible.  Please answer  
the questions to the best of your knowledge. 
 
2.1  How would you rate your overall health before your hospitalization?  
(Read choices and circle response.) 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
-3 
 
-4 
Excellent Very Good Good Fair Poor Unk. Ref. 
 
 
2.2  In general, would you say your health is:  
(Read choices and circle response.) 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
-3 
 
-4 
Excellent Very Good Good Fair Poor Unk. Ref. 
 
 
2.3 How do you think your health will be a year from now?  
(Read choices and circle response.) 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
-3 
 
-4 
Excellent Very Good Good Fair Poor Unk. Ref. 
 
 
3.  Record response to 2.2 on Scoring Sheet, and proceed to Baseline questions 3.2 - 3.5 
 
 
4.  On this board, I’ve recorded how you evaluated your ICU experience in terms of these  
      factors. (Repeat patient’s answers )  
      Would you like to change any of your responses? (Record any changes both on the device,  
      and on the scoring sheet in the CHANGES column.) 
 
 
 
  
5.   PATIENT PREFERENCE:  
      I am asking this question again to see if you have changed your mind after thinking  
      about these factors (gesture to device): 
 
      If you knew then what you know now about the whole experience, would you have  
      chosen to have the breathing tube? 
 
     ___1 Yes              0 No                 -3 Unknown            -4 Refused 
 
 
6.  UNIVARIATE EXERCISE: Do separately for each of 5 factors on scoring sheet, recording 
      both scale position and Would or Would Not on scoring sheet in UNIVARIATE column. 
      When reading the following, select the proper wording based upon the preference recorded 
       in #5 above. 
 
      You said that you would/would not have chosen to have the breathing tube.   
       Imagine now that everything was the same (gesture to device), except that 
 
… your health now was (adjust scale per study instructions). 
     Would you still/then agree to have a breathing tube? 
 
… the pain and discomfort that you experienced from the breathing tube was (adjust scale). 
     Would you still/then agree to have a breathing tube? 
 
… the pain and discomfort that you experienced from being in the ICU was (adjust scale). 
     Would you still/then agree to have a breathing tube? 
 
… your family’s financial burden was (adjust scale). 
     Would you still/then agree to have a breathing tube? 
 
… your family’s emotional and physical stress was  (adjust scale). 
     Would you still/then agree to have a breathing tube? 
 
 
7.  MULTIVARIATE EXERCISE: If the univariate responses are all would not and 0 or  
      all would and 4 then ask: 
 
“Is there any combination of these factors that would make you change your mind and  
refuse/agree to have the breathing tube again?” 
 
If yes,  
 
Hand device to patient and ask them to indicate their answers, assisting if necessary. 
        Record final positions on the scoring sheet in the MULTIVARIATE column. 
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8.  Are there any other factors that could be changed that would make you change  
      your mind and refuse/agree to have the breathing tube again?  
     ( Code 0 if answer is don’t know) 
 
           ____1 Yes              0 No               -4 Refused 
 
      If  Yes, 
 
 
Factor #6:                                                                                                                      
 
Factor #7:                                                                                                                      
 
Factor #8:                                                                                                                      
 
Factor #9:                                                                                                                      
  (30 characters) 
 
 
 
 
9.  Here are the five factors that I was asking you about (show device), and the (x number  
      of factors from question #8) that you mentioned.  Can you rank them for me, in terms of  
      how important they are to you in making the decision of whether to have the breathing  
      tube again? 
(Rank factors, using 1 for most important factor. Code -3  if patient can’t rank a factor.   
 Use -2 in unneeded blanks.) 
 
9.1 Present health status ______ 
9.2 Pain/discomfort from the breathing tube ______ 
9.3 Pain/discomfort in the ICU ______ 
9.4 Financial burden ______ 
9.5 Family’s emotional/physical stress ______ 
9.6 Factor #6 ______ 
9.7 Factor #7 ______ 
9.8 Factor #8 ______ 
9.9 Factor #9 ______ 
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 10. How TRUE or FALSE is the following statement for you?  (Read statement and answer 
choices, and circle response.) 
“I would have survived without the breathing tube.” 
 
1 
 
2 
 
3 
 
4 
 
5 
 
-3 
 
-4 
Definitely 
true 
Mostly 
true 
Neither 
false nor 
true 
Mostly 
false 
Definitely 
false 
Unk. Ref. 
11.INTERVIEWER’S PERCEPTION (not to be read to the patient): 
 Did the patient seem to understand the exercise?   ____0  No      ____1  Yes 
 
12. Comments:  ____0  No      ____1  Yes 
 If yes, 
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 PATIENT PREFERENCE SCORING SHEET 
  
 
 
(Begin with question 3.2 
for BASELINE 
responses) 
 
 
 
BASELINE 
 
 
 
CHANGES 
 
 
 
UNIVARIATE 
MULTIVARIATE 
___ 0 No __-2 N/A 
___ 1Yes ___-3 Unk. 
___-4 Ref. 
If yes,  
 
3.1 In general, would you 
say your health is: 
 
 
 
 
(Copy from 2.2) 
0    1    2    3     4   
 
 
-3 Unk.    -4  Ref  
 
0    1    2    3     4   
 
-2 No change 
-3 Unk.   -4  Ref.
 
   
 
0 
 
-3Unk.-4  Ref. 
Would  
Would Not 
   1       2       3 
 
  
 
4 
 
 
    0     1      2     3     4  
 
  
 
3.2 How much pain or 
discomfort do you 
remember experiencing 
because of the breathing 
tube? 
 
 
 0   1    2    3     4   
 
 -3 Unk.  -4  Ref. 
 
0   1    2     3     4   
 
 -2 No change 
-3 Unk.   -4  Ref.
 
   
 0 
 
-3Unk.-4  Ref. 
Would  
Would Not  
1       2       3 
 
  
4 
 
 
    0     1      2     3     4  
 
  
 
3.3 How much pain or 
discomfort do you 
remember experiencing 
from being in the ICU? 
 
 
0    1    2    3     4   
 
 -3 Unk.  -4  Ref. 
 
0    1    2    3     4   
 
 -2 No change 
-3 Unk.   -4  Ref 
 
   
0 
 
-3 Unk.-4 Ref. 
Would  
Would Not  
1       2       3 
 
  
4 
 
 
    0     1      2     3     4  
 
  
 
3.4 How much of a 
financial burden do you 
think you or your family 
experienced since the 
event that resulted in 
your hospitalization? 
 
 
 0   1    2    3     4   
 
 -3 Unk.  -4  Ref. 
 
0    1   2     3     4   
 
-2 No change 
 
 -3 Unk.  -4  Ref.
 
   
0 
 
-3 Unk. -4Ref. 
Would  
Would Not 
   1       2       3 
 
  
4 
 
 
    0     1      2     3     4  
 
  
 
3.5 How emotionally  
and physically stressful 
do you think it has been 
for your family since the 
event that resulted in 
your hospitalization? 
 
 
 0   1    2    3     4   
 
 -3 Unk.  -4  Ref. 
 
0    1   2     3     4   
 
-2 No change 
 -3 Unk.  -4  Ref.
 
   
 0 
 
-3 Unk.4  Ref. 
Would  
Would Not 
   1       2       3 
 
 
4 
 
 
    0     1      2     3     4  
 
 Record 
responses on 
device, then 
prompt for 
CHANGES (q.4) 
Ask (q.5) and 
proceed with 
UNIVARIATE 
exercise (q.6) 
 
Proceed with 
MULTIVARIATE  
exercise (q.7), if 
all Would not/0  
or all Would/4 
Continue with 
question 8 
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 Present Health Status 
 
|_____________|______________|____________|__________|
Excellent      Very Good          Good                Fair            Poor 
 
Pain/Discomfort from the Breathing Tube 
 
|___________|_____________|_____________|____________|
No          Some              Moderate           Serious       Extreme 
Pain        Pain                  Pain                   Pain           Pain 
 
Pain/Discomfort in the ICU 
 
|___________|_____________|_____________|____________|
No          Some                Moderate           Serious       Extreme 
Pain        Pain                  Pain                   Pain           Pain 
 
Financial Burden 
 
|___________|_____________|_____________|____________|
No               Some           Moderate           Serious       Extreme 
Burden        Burden        Burden               Burden        Burden 
 
Family’s Emotional and Physical Stress 
 
|___________|_____________|_____________|____________|
No          Some                Moderate           Serious       Extreme 
Stress    Stress                Stress                Stress           Stress 
 
 105
 APPENDIX A7 Patient Communication Survey 
 
Please check the box beside the answer that best describes your opinion. 
1. I can make most people understand me without speaking. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
2.  My family can understand me even through I am unable to speak. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
3.  The nurses can understand me even through I am unable to speak. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
4.  The doctors can understand me even through I am unable to speak. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
5.  My way of communicating meets my current needs. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 106
 6.  I can say everything that I need to say right now. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
7.  I am satisfied with the way I communicate in the hospital. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
8.  I have difficulty getting my point across since the (surgery) being on the vent. 
 
 Strongly disagree      
 Disagree      
 Not sure      
 Agree      
 Strongly agree 
 
9.  Not being able to speak makes me feel: 
 
      Angry      
      Frustrated     
      Sad     
      Lonely    
      Don’t Care     
      Quiet 
  
10. Method of communication _________________________________________________ 
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